| World Health Organization | 60.0 | 21 | 0 |
| Fertility and Sterility | 52.3 | 2 | 3 |
| Prelude Fertility | 51.4 | 3 | 2 |
| Pacific Fertility Center Los Angeles (PFCLA) | 51.4 | 3 | 2 |
| Pacific Fertility Center | 42.4 | 3 | 1 |
| Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles | 40.0 | 0 | 5 |
| Colorado Center for Reproductive Medicine | 36.8 | 2 | 1 |
| Shady Grove Fertility Center | 36.8 | 2 | 1 |
| Sher Fertility | 36.8 | 2 | 1 |
| New Hope Fertility Center | 36.8 | 2 | 1 |
| assisted reproductive technology | 35.9 | 0 | 4 |
| What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation? | 35.9 | 0 | 4 |
| Predictors of pregnancy and live-birth in couples with unexplained infertility after ovarian stimulation-intrauterine insemination | 35.9 | 0 | 4 |
| The Management of Uterine Fibroids in Women With Otherwise Unexplained Infertility | 35.9 | 0 | 4 |
| Blastocyst culture and transfer in clinical-assisted reproduction | 35.9 | 0 | 4 |
| Blastocyst Transfer Ameliorates Live Birth Rate Compared with Cleavage-Stage Embryos Transfer in FreshIn VitroFertilization or Intracytoplasmic Sperm Injection Cycles: Reviews and Meta-Analysis | 35.9 | 0 | 4 |
| Blastocyst culture and transfer in clinical-assisted reproduction: a committee opinion | 35.9 | 0 | 4 |
| Luteal-phase ovarian stimulation is a feasible method for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment compared to a GnRH antagonist protocol: A retrospective study | 35.9 | 0 | 4 |
| Association of uterine fibroids and pregnancy outcomes after ovarian stimulation-intrauterine insemination for unexplained infertility. | 35.9 | 0 | 4 |
| Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles | 35.9 | 0 | 4 |
| Impact of single embryo transfer policy on perinatal outcomes in fresh and frozen cycles—analysis of the Japanese Assisted Reproduction Technology registry between 2007 and 2012 | 35.9 | 0 | 4 |
| Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials | 35.9 | 0 | 4 |
| Uncommon but devastating event: total fertilisation failure following intracytoplasmic sperm injection | 35.9 | 0 | 4 |
| The role of in vitro fertilization and intracytoplasmic sperm injection in couples with unexplained infertility after failed intrauterine insemination | 35.9 | 0 | 4 |
| Single embryo implantation per IVF cycle: the answer to every request for assisted reproduction? | 35.9 | 0 | 4 |
| The question of sperm DNA fragmentation testing in the male infertility work-up: a response to Professor Lewis' commentary | 35.9 | 0 | 4 |
| Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART) | 35.9 | 0 | 4 |
| A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) Treatment | 35.9 | 0 | 4 |
| The results of in vitro fertilization-embryo transfer in couples with unexplained infertility failing to conceive with superovulation and intrauterine insemination | 35.9 | 0 | 4 |
| Comparable clinical outcomes of tubal embryo transfer for oligoastheno-teratozoospermia treated with intracytoplasmic sperm injection and for female infertility treated with in vitro fertilization | 35.9 | 0 | 4 |
| Blastocyst culture and transfer in clinical-assisted reproduction | 35.9 | 0 | 4 |
| In vitro fertilization laboratory. Clinical features of assisted reproduction techniques. Male infertility treatment in a reproduction medicine centre | 35.9 | 0 | 4 |
| Outcomes of in vitro fertilization-embryo transfer and intracytoplasmic sperm injection for non-male infertility patients with a low number of oocytes retrieved | 35.9 | 0 | 4 |
| Current Preventive Strategies for Preovulatory Progesterone Elevation During Ovarian Stimulation for In Vitro Fertilization | 35.9 | 0 | 4 |
| Blastocyst culture and transfer in clinically assisted reproduction: a committee opinion | 35.9 | 0 | 4 |
| International Certificate of Vaccination | 31.2 | 4 | 0 |
| Mayo Clinic | 31.2 | 4 | 0 |
| Bulletin of the World Health Organization | 31.2 | 4 | 0 |
| Cleveland Clinic | 31.2 | 4 | 0 |
| fertility clinic | 30.9 | 0 | 3 |
| Post-embryo transfer interventions for in vitro fertilization and intracytoplasmic sperm injection patients | 30.9 | 0 | 3 |
| Post embryo transfer interventions for in vitro fertilization / intracytoplasmic sperm injection patients | 30.9 | 0 | 3 |
| Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection | 30.9 | 0 | 3 |
| Day 3 versus day 2 embryo transfer following in vitro fertilization or intracytoplasmic sperm injection | 30.9 | 0 | 3 |
| In vitromaturation of human oocytes: Its role in infertility treatment and new possibilities | 30.9 | 0 | 3 |
| <i>In vitro</i> fertilization in Japan — Early days of <i>in vitro</i> fertilization and embryo transfer and future prospects for assisted reproductive technology — | 30.9 | 0 | 3 |
| Impact of men's dairy intake on assisted reproductive technology outcomes among couples attending a fertility clinic | 30.9 | 0 | 3 |
| Maternal whole grain intake and outcomes of in vitro fertilization | 30.9 | 0 | 3 |
| Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection. | 30.9 | 0 | 3 |
| The role of assisted hatching in in vitro fertilization: a review of the literature. A committee opinion | 30.9 | 0 | 3 |
| Intrauterine administration of recombinant human chorionic gonadotropin before embryo transfer on outcome of in vitro fertilization/ intracytoplasmic sperm injection: A randomized clinical trial | 30.9 | 0 | 3 |
| Assisted reproduction-in vitro fertilization success is improved by ovarian stimulation with exogenous gonadotropins and pituitary suppression with gonadotropin-releasing hormone analogues | 30.9 | 0 | 3 |
| Serum Progesterone Elevation Adversely Affects Cumulative Live Birth Rate in Different Ovarian Responders during In Vitro Fertilization and Embryo Transfer: A Large Retrospective Study | 30.9 | 0 | 3 |
| Effectiveness of in vitro fertilization with intracytoplasmic sperm injection for severe male infertility. | 30.9 | 0 | 3 |
| The importance of the cleavage stage morphology evaluation for blastocyst transfer in patients with good prognosis | 30.9 | 0 | 3 |
| Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes | 30.9 | 0 | 3 |
| Conversion from assisted reproductive technology to intrauterine insemination in low responders: is it advantageous? | 30.9 | 0 | 3 |
| Risk of breast cancer following fertility treatment—A registry based cohort study of parous women in Norway | 30.9 | 0 | 3 |
| Prevention of multiple pregnancies in couples with unexplained or mild male subfertility: randomised controlled trial of in vitro fertilisation with single embryo transfer or in vitro fertilisation in modified natural cycle compared with intrauterin | 30.9 | 0 | 3 |
| In vitro fertilization/intracytoplasmic sperm injection for male infertility | 30.9 | 0 | 3 |
| Intrafollicular cortisol levels inversely correlate with cumulus cell lipid content as a possible energy source during oocyte meiotic resumption in women undergoing ovarian stimulation for in vitro fertilization | 30.9 | 0 | 3 |
| Clinical analysis of spontaneous pregnancy reduction in the patients with multiple pregnancies undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer | 30.9 | 0 | 3 |
| Does obesity have detrimental effects on IVF treatment outcomes? | 30.9 | 0 | 3 |
| Human iPS Cell-Derived Germ Cells: Current Status and Clinical Potential | 30.9 | 0 | 3 |
| Predictive value of sperm motility characteristics assessed by computer-assisted sperm analysis in intrauterine insemination with superovulation in couples with unexplained infertility | 30.9 | 0 | 3 |
| Patients with polycystic ovary syndrome have successful embryo arrest | 30.9 | 0 | 3 |
| Management of the first in vitro fertilization cycle for unexplained infertility: a cost-effectiveness analysis of split in vitro fertilization-intracytoplasmic sperm injection | 30.9 | 0 | 3 |
| Clinical application of sperm-oocyte interaction tests in in vitro fertilization--embryo transfer and intracytoplasmic sperm injection programs | 30.9 | 0 | 3 |
| Gonadotrophin ovarian stimulation and intrauterine insemination for unexplained infertility | 30.9 | 0 | 3 |
| ICSI treatment of severe male infertility can achieve prospective embryo quality compared with IVF of fertile donor sperm on sibling oocytes | 30.9 | 0 | 3 |
| Phospholipase C-zeta deficiency as a cause for repetitive oocyte fertilization failure during ovarian stimulation for in vitro fertilization with ICSI: a case report | 30.9 | 0 | 3 |
| The association of serum estradiol level with outcomes of clomiphene citrate/human menopausal gonadotropin ovarian stimulation for in vitro fertilization and embryo transfer | 30.9 | 0 | 3 |
| Pregnancy outcome of assisted reproductive technology cycle in patients with hypogonadotropic hypogonadism | 30.9 | 0 | 3 |
| Effect of endometrial biopsy on intrauterine insemination outcome in controlled ovarian stimulation cycle | 30.9 | 0 | 3 |
| Three pro-nuclei (3PN) incidence factors and clinical outcomes: a retrospective study from the fresh embryo transfer of in vitro fertilization with donor sperm (IVF-D) | 30.9 | 0 | 3 |
| A prospective randomized trial of conventional in vitro fertilization versus intracytoplasmic sperm injection in unexplained infertility | 30.9 | 0 | 3 |
| In vitro fertilization and intracytoplasmic sperm injection for couples with unexplained infertility after failed direct intraperitoneal insemination | 30.9 | 0 | 3 |
| Is intracytoplasmic sperm injection necessary for couples undergoing in vitro fertilization-embryo transfer with normal semen analyses but failing hamster egg penetration assays? | 30.9 | 0 | 3 |
| Intracytoplasmic sperm injection and conventional in vitro fertilization are complementary techniques in management of unexplained infertility. | 30.9 | 0 | 3 |
| Recruiting egg donors online: an analysis of in vitro fertilization clinic and agency websites' adherence to American Society for Reproductive Medicine guidelines | 30.9 | 0 | 3 |
| A global perspective on assisted reproductive technology fertility treatment: an 8-country fertility specialist survey | 30.9 | 0 | 3 |
| Identification of small segmental translocations in patients with repeated implantation failure and recurrent miscarriage using next generation sequencing after in vitro fertilization/intracytoplasmic sperm injection | 30.9 | 0 | 3 |
| Embryo transfer in days 2 to 4 following intracytoplasmic sperm injection: a prospective cohort study | 30.9 | 0 | 3 |
| Anti-Müllerian hormone levels as a predictor of clinical pregnancy inin vitrofertilization/intracytoplasmic sperm injection-embryo transfer cycles in patients over 40 years of age | 30.9 | 0 | 3 |
| Genetic considerations related to intracytoplasmic sperm injection (ICSI). | 30.9 | 0 | 3 |
| The Effects of Total Motile Sperm Count on Spontaneous Pregnancy Rate and Pregnancy After IUI Treatment in Couples with Male Factor and Unexplained Infertility | 30.9 | 0 | 3 |
| Comparing blastocyst quality and live birth rates of intravaginal culture using INVOcell™ to traditional in vitro incubation in a randomized open-label prospective controlled trial | 30.9 | 0 | 3 |
| Recent data on the treatment of unexplained infertility with clomiphene citrate, intrauterine insemination, and in vitro fertilization | 30.9 | 0 | 3 |
| Outcomes of intracytoplasmic sperm injection using the zona pellucida-bound sperm or manually selected sperm | 30.9 | 0 | 3 |
| Preimplantation genetic testing: a Practice Committee opinion | 30.9 | 0 | 3 |
| Providing fertility care to men seropositive for human immunodeficiency virus: reviewing 10 years of experience and 420 consecutive cycles of in vitro fertilization and intracytoplasmic sperm injection | 30.9 | 0 | 3 |
| A prospective randomized study to evaluate the effect of hyaluronic acid sperm selection on the intracytoplasmic sperm injection outcome of patients with unexplained infertility having normal semen parameters | 30.9 | 0 | 3 |
| Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome | 30.9 | 0 | 3 |
| Limb-body wall complex in one fetus of a dizygotic twin pregnancy conceived by egg donation, in vitro fertilization and embryo transfer: prenatal diagnosis and literature review | 30.9 | 0 | 3 |
| The promise of in vitro maturation in assisted reproduction and fertility preservation. | 30.9 | 0 | 3 |
| Elective single-embryo transfer | 30.9 | 0 | 3 |
| Intracytoplasmic sperm injection (ICSI) for non-male factor infertility: a committee opinion | 30.9 | 0 | 3 |
| In vitro maturation: a committee opinion | 30.9 | 0 | 3 |
| VACTERL association with hydrocephalus in a fetus conceived by in vitro fertilization and embryo transfer | 30.9 | 0 | 3 |
| Cervical mucus removal before embryo transfer in women undergoing in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials. | 30.9 | 0 | 3 |
| The use of in vitro fertilization in the management of male infertility: what the urologist needs to know | 30.9 | 0 | 3 |
| Timing of human chorionic gonadotropin (hCG) hormone administration in IVF/ICSI protocols using GnRH agonist or antagonists: a systematic review and meta-analysis | 30.9 | 0 | 3 |
| Clinical rationale for cryopreservation of entire embryo cohorts in lieu of fresh transfer | 30.9 | 0 | 3 |
| Role of assisted hatching in in vitro fertilization: a guideline | 30.9 | 0 | 3 |
| Anticoagulation and in vitro fertilization and ovarian stimulation | 30.9 | 0 | 3 |
| Effect of Prednisolone Administration on Patients with Unexplained Recurrent Miscarriage and in Routine Intracytoplasmic Sperm Injection: A Meta‐Analysis | 30.9 | 0 | 3 |
| Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination | 30.9 | 0 | 3 |
| Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen–thawed embryo transfer in normal responders | 30.9 | 0 | 3 |
| Influence of female age on pregnancy outcome in in vitro fertilization and embryo transfer patients undergoing intracytoplasmic sperm injection | 30.9 | 0 | 3 |
| The outcome of in vitro fertilization and embryo transfer in women with polycystic ovary syndrome failing to conceive after ovulation induction with exogenous gonadotropins | 30.9 | 0 | 3 |
| Impact of equine assisted reproductive technologies (standard embryo transfer or intracytoplasmic sperm injection (ICSI) with in vitro culture and embryo transfer) on placenta and foal morphometry and placental gene expression. | 30.9 | 0 | 3 |
| Embryo transfer techniques: an American Society for Reproductive Medicine survey of current Society for Assisted Reproductive Technology practices | 30.9 | 0 | 3 |
| Normal birth after single-embryo transfer in a patient with excessive polypronuclear zygote formation following in vitro fertilization and intracytoplasmic sperm injection | 30.9 | 0 | 3 |
| Couples with unexplained subfertility and unfavorable prognosis: a randomized pilot trial comparing the effectiveness of in vitro fertilization with elective single embryo transfer versus intrauterine insemination with controlled ovarian stimulation | 30.9 | 0 | 3 |
| Ovarian stimulation with clomiphene and/or human menopausal gonadotropin (HMG) for in vitro fertilization (IVF) and embryo transfer (ET). | 30.9 | 0 | 3 |
| In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. | 30.9 | 0 | 3 |
| Determining the need for rescue intracytoplasmic sperm injection in partial fertilisation failure during a conventional IVF cycle | 30.9 | 0 | 3 |
| Clinical outcomes of frozen-thawed single blastocyst transfer in patients requiring whole embryo freezing | 30.9 | 0 | 3 |
| Assisted reproduction policies in Israel: a retrospective analysis of in vitro fertilization–embryo transfer | 30.9 | 0 | 3 |
| Physical health of singleton children born after frozen embryo transfer using slow freezing: a 3-year follow-up study | 30.9 | 0 | 3 |
| The relationship between the changes in the level of progesterone and the outcome ofin vitrofertilization-embryo transfer | 30.9 | 0 | 3 |
| Mature oocyte cryopreservation: a guideline | 30.9 | 0 | 3 |
| Fertility preservation by ovarian stimulation and oocyte cryopreservation in a 14-year-old adolescent with Turner syndrome mosaicism and impending premature ovarian failure | 30.9 | 0 | 3 |
| Economic evaluation of elective single-embryo transfer with subsequent single frozen embryo transfer in an in vitro fertilization/intracytoplasmic sperm injection program | 30.9 | 0 | 3 |
| Recommendations for development of an emergency plan for in vitro fertilization programs: a committee opinion | 30.9 | 0 | 3 |
| Guidelines for development of an emergency plan for in vitro fertilization programs | 30.9 | 0 | 3 |
| Ovarian stimulation and corpus luteum function in human in vitro fertilization and embryo transfer | 30.9 | 0 | 3 |
| Comparison of Alarelin and Triptorelin in the long-protocol ovulation induction in in vitro fertilization and embryo transfer | 30.9 | 0 | 3 |
| Assisted reproduction: an important review of the literature on the risk of malformation after in vitro fertilization and intracytoplasmic sperm injection | 30.9 | 0 | 3 |
| Pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women aged < 37, undergoing ovulation induction with human FSH compared with recombinant FSH: a randomised controlled study | 30.9 | 0 | 3 |
| Lyophilised hMG versus rFSH in women with unexplained infertility undergoing a controlled ovarian stimulation with intrauterine insemination: a prospective, randomised study. | 30.9 | 0 | 3 |
| Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients | 30.9 | 0 | 3 |
| Comparison of the Outcome of Conventional in vitro Fertilization and Intracytoplasmic Sperm Injection in Moderate Male Infertility from Ejaculate | 30.9 | 0 | 3 |
| Serum human chorionic gonadotropin levels are correlated with body mass index rather than route of administration in women undergoing in vitro fertilization--embryo transfer using human menopausal gonadotropin and intracytoplasmic sperm injection | 30.9 | 0 | 3 |
| Ovarian stimulation in intrauterine insemination with donor sperm: a randomized study comparing clomiphene citrate in fixed protocol versus highly purified urinary FSH. | 30.9 | 0 | 3 |
| Intrauterine insemination with frozen donor sperm. Pregnancy outcome in relation to age and ovarian stimulation regime | 30.9 | 0 | 3 |
| Cycle-specific and cumulative fecundity in patients with endometriosis who are undergoing controlled ovarian hyperstimulation-intrauterine insemination or in vitro fertilization-embryo transfer | 30.9 | 0 | 3 |
| Impact of high response of ovary to gonadotropin stimulation on the outcome of in vitro fertilization and embryo transfer or intracytoplasmic sperm injection | 30.9 | 0 | 3 |
| Personal experience with ovarian stimulation in an in vitro fertilization and embryo transfer program | 30.9 | 0 | 3 |
| Optimal treatment for poor responders to ovarian stimulation: does in vitro insemination offer any advantages to intrauterine insemination? | 30.9 | 0 | 3 |
| Egg donation in an in vitro fertilization program: an alternative approach to cycle synchronization and timing of embryo transfer | 30.9 | 0 | 3 |
| Twin pregnancy outcome among cases of spontaneous conception, intrauterine insemination, and in vitro fertilization/intracytoplasmic sperm injection | 30.9 | 0 | 3 |
| Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotropin versus pure human follicle stimulating hormone: a randomized prospective study. | 30.9 | 0 | 3 |
| Embryo transfer by reproductive endocrinology fellows vs attending physicians: are live birth rates comparable? | 30.9 | 0 | 3 |
| Comparison of clinical outcome of mild-stimulation and conventional ovarian stimulation in in vitro fertilization-embryo transfer (IVF-ET) | 30.9 | 0 | 3 |
| Perspective on in vitro fertilization and embryo transfer. Stimulus for biomedical research in reproductive medicine | 30.9 | 0 | 3 |
| Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility. | 30.9 | 0 | 3 |
| Efficacy and safety of frozen-thawed embryo transfer in women aged 35 to 42 years from the PURSUE randomized clinical trial | 30.9 | 0 | 3 |
| First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient | 30.9 | 0 | 3 |
| Comparison of the efficacy of treating sperm with low hypoosmotic swelling test scores with chymotrypsin followed by intrauterine insemination vs in vitro fertilization with intracytoplasmic sperm injection | 30.9 | 0 | 3 |
| Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation | 30.9 | 0 | 3 |
| Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction-intrauterine insemination to in vitro fertilization conversions, independent of age and estradiol level on the day of human chorionic g | 30.9 | 0 | 3 |
| Ovarian stimulation, egg aspiration, in vitro fertilization and embryo transfer in the baboon (Papio anubis): a pilot project at the Institute of Primate Research, Nairobi, Kenya | 30.9 | 0 | 3 |
| Analysis of pregnancy outcomes after in vitro fertilization-embryo transfer and intracytoplasmic sperm injection | 30.9 | 0 | 3 |
| Intracytoplasmic sperm injection and conventional in vitro fertilization for sibling oocytes in cases of unexplained infertility and borderline semen | 30.9 | 0 | 3 |
| Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation | 30.9 | 0 | 3 |
| Antral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilization outcome in an egg donation program | 30.9 | 0 | 3 |
| Retracted: Cervical mucus removal prior to intrauterine insemination: a randomized trial | 30.9 | 0 | 3 |
| The significance of antral follicle count in controlled ovarian stimulation and intrauterine insemination | 30.9 | 0 | 3 |
| Racial Disparities in Fertility Care: an Analysis of 4537 Intrauterine Insemination Cycles | 30.9 | 0 | 3 |
| Luteal estrogen supplementation in stimulated cycles may improve the pregnancy rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer | 30.9 | 0 | 3 |
| A controlled study between the use of gamete intrafallopian transfer (GIFT) and in vitro fertilization and embryo transfer in the management of idiopathic and male infertility | 30.9 | 0 | 3 |
| Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial | 30.9 | 0 | 3 |
| Reprotoxicity of intrauterine insemination and in vitro fertilization-embryo transfer disposables and products: a 4-year survey | 30.9 | 0 | 3 |
| Congenital Malformations in Singleton Infants Conceived by Assisted Reproductive Technologies and Singleton Infants by Natural Conception in Tehran, Iran | 30.9 | 0 | 3 |
| A Focus on Maternal Health Before Assisted Reproduction: Results From a Pilot Survey of Canadian IVF Medical Directors | 30.9 | 0 | 3 |
| Effect of male body mass index on live-birth sex ratio of singletons after assisted reproduction technology | 30.9 | 0 | 3 |
| Comparison of pregnancy rates in pre-treatment male infertility and low total motile sperm count at insemination | 30.9 | 0 | 3 |
| The use of luteal-phase ovarian stimulation for poor ovarian responders undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer treatment | 30.9 | 0 | 3 |
| Effect of premature serum progesterone rise on embryo transfer outcomes and the role of blastocyst culture and transfer in assisted reproductive technology cycles with premature progesterone rise | 30.9 | 0 | 3 |
| Progestin-primed ovarian stimulation with or without clomiphene citrate supplementation in normal ovulatory women undergoing in vitro fertilization/intracytoplasmic sperm injection: A prospective randomized controlled trial. | 30.9 | 0 | 3 |
| Melatonin concentration in follicular fluid is correlated with antral follicle count (AFC) and in vitro fertilization (IVF) outcomes in women undergoing assisted reproductive technology (ART) procedures. | 30.9 | 0 | 3 |
| Effect of endometrial thickness on pregnancy outcome after intracytoplasmic sperm injection | 30.9 | 0 | 3 |
| Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET | 30.9 | 0 | 3 |
| Comparison of estradiol and progesterone priming/antagonist/letrozole and microdose flare-up protocols for poor responders undergoing intracytoplasmic sperm injection | 30.9 | 0 | 3 |
| Embryo quality in controlled ovarian stimulation forin vitrofertilization in young poor responders | 30.9 | 0 | 3 |
| Pregnancy rates in donor oocyte cycles compared to similar autologous in vitro fertilization cycles: an analysis of 26,457 fresh cycles from the Society for Assisted Reproductive Technology | 30.9 | 0 | 3 |
| Can intracytoplasmic sperm injection prevent total fertilization failure and enhance embryo quality in patients with non-male factor infertility? | 30.9 | 0 | 3 |
| What is the quality of information on social oocyte cryopreservation provided by websites of Society for Assisted Reproductive Technology member fertility clinics? | 30.9 | 0 | 3 |
| Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonis | 30.9 | 0 | 3 |
| Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm injection treatment cycle: impact on ovarian stimulation. A pilot study | 30.9 | 0 | 3 |
| Overweight and obesity negatively affect the outcomes of ovarian stimulation andin vitrofertilisation: a cohort study of 2628 Chinese women | 30.9 | 0 | 3 |
| Essential elements of informed consent for elective oocyte cryopreservation: a Practice Committee opinion | 30.9 | 0 | 3 |
| Comparative study of intracytoplasmic sperm injection and in vitro fertilization with high insemination concentration in sibling oocytes in the treatment of unexplained infertility. | 30.9 | 0 | 3 |
| Guidelines for development of an emergency plan for in vitro fertilization programs | 30.9 | 0 | 3 |
| Good results of milder form of ovarian stimulation in an in vitro fertilization/intracytoplasmic sperm injection program | 30.9 | 0 | 3 |
| Clinical application of intracytoplasmic sperm injection using in vitro cultured testicular spermatozoa obtained the day before egg retrieval | 30.9 | 0 | 3 |
| Multinucleation in normally fertilized embryos is associated with an accelerated ovulation induction response and lower implantation and pregnancy rates in in vitro fertilization-embryo transfer cycles | 30.9 | 0 | 3 |
| Parameters that influence the results of in vitro fertilization/embryo transfer: a study of an egg donation model | 30.9 | 0 | 3 |
| Outcome of donor versus husband insemination in couples with unexplained infertility treated by in vitro fertilization and embryo transfer | 30.9 | 0 | 3 |
| A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program | 30.9 | 0 | 3 |
| Efficacy and safety of Ding-Kun-Dan for female infertility patients with predicted poor ovarian response undergoing in vitro fertilization/intracytoplasmic sperm injection: study protocol for a randomized controlled trial | 30.9 | 0 | 3 |
| Infertility treatment strategy involving combined freeze-all embryos and single vitrified-warmed embryo transfer during hormonal replacement cycle for in vitro fertilization of women with hypogonadotropic hypogonadism | 30.9 | 0 | 3 |
| Male Infertility Diagnosis and Treatment in the Era of In Vitro Fertilization and Intracytoplasmic Sperm Injection | 30.9 | 0 | 3 |
| CLINICAL ASSISTED REPRODUCTION: Comparison of Recombinant and Urinary Follicle-Stimulating Hormone Preparations in Short-Term Gonadotropin Releasing Hormone Agonist Protocol for In Vitro Fertilization-Embryo Transfer | 30.9 | 0 | 3 |
| The effect of endometrial thickness on in vitro fertilization (IVF)-embryo transfer/intracytoplasmic sperm injection (ICSI) outcome | 30.9 | 0 | 3 |
| Immunomodulatory treatment with intravenous immunoglobulin and prednisone in patients with recurrent miscarriage and implantation failure after in vitro fertilization/intracytoplasmic sperm injection | 30.9 | 0 | 3 |
| An online survey of specialists’ opinion on first line management options for unexplained subfertility | 30.9 | 0 | 3 |
| Perinatal outcomes of intrauterine insemination/clomiphene pregnancies represent an intermediate risk group compared with in vitro fertilisation/intracytoplasmic sperm injection and naturally conceived pregnancies | 30.9 | 0 | 3 |
| The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer | 30.9 | 0 | 3 |
| Further observations on serial serum immunoreactive inhibin levels in the luteal phase and early gestation after ovarian stimulation for in vitro fertilization and embryo transfer | 30.9 | 0 | 3 |
| Comparison of four different ovarian stimulation protocols in an in vitro fertilisation & embryo transfer programme | 30.9 | 0 | 3 |
| Factors influencing the success rate of human embryo freezing in an in vitro fertilization and embryo transfer program. | 30.9 | 0 | 3 |
| Beyond the American Society for Reproductive Medicine transfer guidelines: how many cleavage-stage embryos are safe to transfer in women ≥43 years old? | 30.9 | 0 | 3 |
| Re: Effect of Semen Quality on Human Sex Ratio in In Vitro Fertilization and Intracytoplasmic Sperm Injection: An Analysis of 27,158 Singleton Infants Born after Fresh Single-Embryo Transfer | 30.9 | 0 | 3 |
| Association Between Progesterone Elevation on the Day of Human Chronic Gonadotropin Trigger and Pregnancy Outcomes After Fresh Embryo Transfer in In Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles. | 30.9 | 0 | 3 |
| Retrospective Study to Compare Frozen-Thawed Embryo Transfer with Fresh Embryo Transfer on Pregnancy Outcome Following Intracytoplasmic Sperm Injection for Male Infertility. | 30.9 | 0 | 3 |
| Effect of oocyte transportation time on the clinical results of transport in vitro fertilization/intracytoplasmic sperm injection-embryo transfer | 30.9 | 0 | 3 |
| Association of the peripheral blood levels of circulating microRNAs with both recurrent miscarriage and the outcomes of embryo transfer in an in vitro fertilization process | 30.9 | 0 | 3 |
| Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection: a multicenter multinational analysis including ∼15,000 women | 30.9 | 0 | 3 |
| The use of anti-Müllerian hormone for controlled ovarian stimulation in assisted reproductive technology, fertility assessment and -counseling | 30.9 | 0 | 3 |
| Meta-analysis of the association between chromosomal polymorphisms and outcomes of embryo transfer following in vitro fertilization and/or intracytoplasmic sperm injection | 30.9 | 0 | 3 |
| Sharing of human leukocyte antigens in couples with unexplained infertility affects the success of in vitro fertilization and tubal embryo transfer | 30.9 | 0 | 3 |
| THE OPTIMAL INTERVAL OF TIME FROM OPERATIVE HYSTEROSCOPY TO EMBRYO TRANSFER IN AN IVF CYCLE | 30.9 | 0 | 3 |
| Unexplained Infertility and the Possibilities of Management with In Vitro Fertilization and Embyro Transfer | 30.9 | 0 | 3 |
| The relationship of tubal blockage, infertility of unknown cause, suspected male infertility, and endometriosis to success of in vitro fertilization and embryo transfer | 30.9 | 0 | 3 |
| EXpression PRofile Endometrium Samples Study | 30.9 | 0 | 3 |
| Comparison of the Number of Oocytes Obtained Between Chinese and Caucasian Women in IVF Treatment | 30.9 | 0 | 3 |
| Intralipid Therapy for Women 35-40 Years With Positive Natural Killer Cells Undergoing Intracytoplasmic Sperm Injection (ICSI) | 30.9 | 0 | 3 |
| Anti-Mullerian Hormone (AMH) Versus Antral Follicle Count (AFC) Guided rFSH Dosing Study | 30.9 | 0 | 3 |
| A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment | 30.9 | 0 | 3 |
| Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT | 30.9 | 0 | 3 |
| Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro Fertilization | 30.9 | 0 | 3 |
| The Effect of Selective Serotonin Reuptake Inhibitor (SSRI) Treatment on Affective Symptoms and Fertility Treatment Outcome in Women Undergoing in Vitro Fertilization (IVF) | 30.9 | 0 | 3 |
| Letrozole Combined With Gonadotropins (Gn) for Ovarian Stimulation Undergoing in Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) in Patients With Polycystic Ovary Syndrome (PCOS) | 30.9 | 0 | 3 |
| Egg Freezing Pilot Study | 30.9 | 0 | 3 |
| Fertility Preservation by Ovarian and Oocyte Cryopreservation | 30.9 | 0 | 3 |
| ICSI Versus Conventional IVF in Couples With Non-severe Male Infertility | 30.9 | 0 | 3 |
| Clinical outcomes following long GnRHa ovarian stimulation with highly purified human menopausal gonadotropin plus rFSH or rFSH in patients undergoing in vitro fertilization-embryo transfer: a multi-center randomized controlled trial. | 30.9 | 0 | 3 |
| Role of Follicular Output Rate in the Prediction of in Vitro Fertilization and Intracytoplasmic Sperm Injection in Women With Unexplained Infertility | 30.9 | 0 | 3 |
| Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH Antagonist | 30.9 | 0 | 3 |
| Patient-Centered Implementation Trial for Single Embryo Transfer | 30.9 | 0 | 3 |
| Acupuncture for Treatment of Patients With Poor Ovarian Response | 30.9 | 0 | 3 |
| Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF Treatment | 30.9 | 0 | 3 |
| NATural Ovarian Stimulation | 30.9 | 0 | 3 |
| Mitochondrial Energy Production in ART (Assisted Reproductive Technology ) | 30.9 | 0 | 3 |
| In vitro fertilization-embryo transfer (IVF-ET) in the United States: 1990 results from the IVF-ET Registry. Medical Research International. Society for Assisted Reproductive Technology (SART), The American Fertility Society | 30.9 | 0 | 3 |
| The performance of primary and secondary unexplained infertility in an in vitro fertilization-embryo transfer program | 30.9 | 0 | 3 |
| In vitro fertilization-embryo transfer (IVF-ET) in the United States: 1989 results from the IVF-ET Registry. Medical Research International, Society for Assisted Reproductive Technology, The American Fertility Society | 30.9 | 0 | 3 |
| In vitro fertilization-embryo transfer in the United States: 1988 results from the IVF-ET Registry. Medical Research International. Society for Assisted Reproductive Technology. American Fertility Society | 30.9 | 0 | 3 |
| Pregnancy after in vitro fertilization and embryo transfer in severe immune male infertility | 30.9 | 0 | 3 |
| Differential indications for surgical technics in reproductive medicine--microsurgery, in vitro fertilization and embryo transfer, gamete intrafallopian transfer and tubal embryo transfer | 30.9 | 0 | 3 |
| In vitro fertilization and embryo transfer: an individualized approach to ovulation induction | 30.9 | 0 | 3 |
| Characterization and response of women undergoing repeat cycles of ovulation induction in an in vitro fertilization and embryo transfer program | 30.9 | 0 | 3 |
| Clomiphene-HMG ovarian stimulation in human in vitro fertilization and embryo transfer | 30.9 | 0 | 3 |
| Fertilization in vitro and embryo transfer. Comparison of results of 3 methods of ovulation induction | 30.9 | 0 | 3 |
| In vitro fertilization and other assisted reproduction. Vth World Congress on In Vitro Fertilization and Embryo Transfer. Norfolk, Virginia, April 5-10, 1987. Proceedings | 30.9 | 0 | 3 |
| An analysis of the LH profile in relation to ovarian stimulation regimes and embryo transfer rates in an in vitro fertilisation programme | 30.9 | 0 | 3 |
| The effect of periovarian adhesions on follicular development in patients undergoing ovarian stimulation for in vitro fertilization-embryo transfer | 30.9 | 0 | 3 |
| Gamete intra-Fallopian transfer or in-vitro fertilization after failed ovarian stimulation and intrauterine insemination in unexplained infertility? | 30.9 | 0 | 3 |
| Will embryo transfer after in vitro fertilization become one of the standard therapeutic methods for female infertility? | 30.9 | 0 | 3 |
| Randomized comparison of ovulation induction with and without intrauterine insemination in the treatment of unexplained infertility | 30.9 | 0 | 3 |
| In vitro fertilization/embryo transfer in unexplained infertility and minimal peritoneal endometriosis | 30.9 | 0 | 3 |
| Ovulation induction with gonadotropins and intrauterine insemination compared with in vitro fertilization and no therapy: a prospective, nonrandomized, cohort study and meta-analysis | 30.9 | 0 | 3 |
| A prospective randomized crossover comparison of zygote intrafallopian transfer and in vitro fertilization-embryo transfer in unexplained infertility | 30.9 | 0 | 3 |
| A comparison of early gestational age markers in viable twin pregnancies resulting from in vitro fertilization-embryo transfer versus spontaneous conception with ovarian stimulation | 30.9 | 0 | 3 |
| The Predictive Value of the Sperm‐Cervical Mucus Interaction Test on the Outcome of In Vitro Fertilization and Ovulation Induction Combined with Intrauterine Insemination | 30.9 | 0 | 3 |
| A case of forearm amputation after ovarian stimulation for in vitro fertilization-embryo transfer | 30.9 | 0 | 3 |
| First established pregnancy and birth after induction of ovulation with recombinant human follicle stimulating hormone during in vitro fertilization-embryo transfer and intracytoplasmic sperm injection | 30.9 | 0 | 3 |
| Comparison of pronuclear stage embryo transfer and in vitro fertilization-embryo transfer following intracytoplasmic sperm injection | 30.9 | 0 | 3 |
| Intrauterine insemination IUI: the effect of ovarian stimulation and infertility diagnosis on pregnancy outcome | 30.9 | 0 | 3 |
| Pregnancy outcomes using donor sperm insemination after failed in vitro fertilization with intracytoplasmic sperm injection cycles in couples with complex infertility disorders | 30.9 | 0 | 3 |
| The role of assisted hatching in in vitro fertilization: a review of the literature. A Committee opinion | 30.9 | 0 | 3 |
| Ovarian tissue and oocyte cryopreservation | 30.9 | 0 | 3 |
| Assessment of United States fertility clinic websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines | 30.9 | 0 | 3 |
| Effect of early cleavage of embryos after intracytoplasmic sperm injection (ICSI) into oocytes on results of fertilization in vitro (IVF) and embryo transfer (ET) | 30.9 | 0 | 3 |
| The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society for Assisted Reproductive Technology/American Society for Reproductive Medicine recommendation | 30.9 | 0 | 3 |
| Comparison of intrauterine insemination and in vitro fertilization for the treatment of unexplained infertility | 30.9 | 0 | 3 |
| Relative contribution of ovarian stimulation versus in vitro fertilization and intracytoplasmic sperm injection to multifetal pregnancies requiring reduction to twins | 30.9 | 0 | 3 |
| Parabolic trend in endometrial thickness at embryo transfer in in vitro fertilization/intracytoplasmic sperm injection cases with clinical pregnancy evidence | 30.9 | 0 | 3 |
| Preimplantation genetic testing: a Practice Committee opinion | 30.9 | 0 | 3 |
| Genetic considerations related to intracytoplasmic sperm injection (ICSI) | 30.9 | 0 | 3 |
| The role of assisted hatching in in vitro fertilization: a review of the literature. A Committee opinion | 30.9 | 0 | 3 |
| Ovarian tissue and oocyte cryopreservation | 30.9 | 0 | 3 |
| Acupuncture intervention combined with assisted reproductive technology: its different effects at different time points during the in vitro fertilization-embryo transfer course | 30.9 | 0 | 3 |
| Magnetic resonance imaging demonstration of sirenomelia in one fetus of a dizygotic twin pregnancy conceived by intracytoplasmic sperm injection, in vitro fertilization and embryo transfer | 30.9 | 0 | 3 |
| Prediction of ovarian reserve, poor response and pregnancy outcome based on basal antral follicle count and age in patients undergoing in vitro fertilization-embryo transfer | 30.9 | 0 | 3 |
| Recombinant FSH versus clomiphene citrate for ovarian stimulation in couples with unexplained infertility and male subfertility undergoing intrauterine insemination: a randomized trial | 30.9 | 0 | 3 |
| Fertilization rates following 109 half intracytoplasmic sperm injection cycles for in vitro fertilization-embryo transfer | 30.9 | 0 | 3 |
| In vitro fertilization versus intracytoplasmic sperm injection for primary and secondary infertility using sibling oocytes: clinical analysis of the outcomes | 30.9 | 0 | 3 |
| Leptin levels in women with polycystic ovaries undergoing ovarian stimulation: relation to lipoprotein profiles | 30.9 | 0 | 3 |
| Monozygotic twinning after in vitro fertilization/intracytoplasmic sperm injection treatment is not related to advanced maternal age, intracytoplasmic sperm injection, assisted hatching, or blastocyst transfer | 30.9 | 0 | 3 |
| Factors related to clinical pregnancy outcomes of in vitro fertilization-embryo transfer in women with secondary infertility | 30.9 | 0 | 3 |
| Fertility preservation in breast cancer patients by embryo cryopreservation after ovarian stimulation with letrozole and FSH | 30.9 | 0 | 3 |
| Concordant myelomeningocele in dizygotic twins conceived by intracytoplasmic sperm injection, in vitro fertilization, and embryo transfer | 30.9 | 0 | 3 |
| Use of reproductive technology for sex selection for nonmedical reasons | 30.9 | 0 | 3 |
| Processing of semen by density gradient centrifugation selects spermatozoa with longer telomeres for assisted reproduction techniques | 30.9 | 0 | 3 |
| Thyroid function for infertile women during ovarian hyperstimulation as part of IVF | 30.9 | 0 | 3 |
| Prenatal diagnosis of hypomethylation at KvDMR1 and Beckwith–Wiedemann syndrome in a pregnancy conceived by intracytoplasmic sperm injection and in vitro fertilization and embryo transfer | 30.9 | 0 | 3 |
| The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion | 30.9 | 0 | 3 |
| Use of exogenous gonadotropins for ovulation induction in anovulatory women: a committee opinion | 30.9 | 0 | 3 |
| Predictors of twin pregnancy after ovarian stimulation and intrauterine insemination in women with unexplained infertility | 30.9 | 0 | 3 |
| Live birth rate comparison of three controlled ovarian stimulation protocols for in vitro fertilization-embryo transfer in patients with diminished ovarian reserve after endometrioma cystectomy: a retrospective study | 30.9 | 0 | 3 |
| Elective Single Embryo Transfer in the Setting of Funded In Vitro Fertilization: Two Years' Experience in an Ontario Hospital-Based Fertility Clinic | 30.9 | 0 | 3 |
| Intracytoplasmic sperm injection (ICSI) versus conventional in vitro fertilisation (IVF) in couples with non-severe male infertility (NSMI-ICSI): protocol for a multicentre randomised controlled trial | 30.9 | 0 | 3 |
| Curative effect of assisted reproduction technology by Traditional Chinese Medicine multi-channel interventional therapy on 95 cases of in vitro fertilization and embryo transfer failure | 30.9 | 0 | 3 |
| Androgenicity and fertility treatment in women with unexplained infertility | 30.9 | 0 | 3 |
| The effects of intrauterine insemination and single embryo transfer or modified natural cycle in vitro fertilization on offspring's health-Follow-up of a randomized clinical trial | 30.9 | 0 | 3 |
| Assessment of Turkey IVF (In Vitro Fertilization) websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines | 30.9 | 0 | 3 |
| Vitamin D Deficiency Is Associated With Poor Ovarian Stimulation Outcome in PCOS but Not Unexplained Infertility | 30.9 | 0 | 3 |
| Prospective randomized trial comparing efficacy of letrozole step-up protocol with letrozole plus gonadotropins for controlled ovarian stimulation and intrauterine insemination in patients with unexplained infertility | 30.9 | 0 | 3 |
| Efficacy and safety of moxibustion in female infertility patients undergoing in vitro fertilization and embryo transfer: A systematic review protocol | 30.9 | 0 | 3 |
| Association between serum homocysteine level and unexplained infertility in in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI): A retrospective, hospital-based, case-control study | 30.9 | 0 | 3 |
| Different progestin-primed ovarian stimulation protocols in infertile women undergoing in vitro fertilization/intracytoplasmic sperm injection: an analysis of 1188 cycles | 30.9 | 0 | 3 |
| Analysis of embryo quality with luteal phase ovarian stimulation after failed in vitro fertilization-embryo transfer with long or ultra-long protocol | 30.9 | 0 | 3 |
| Ovarian stimulation for fertility preservation or family building in a cohort of transgender men | 30.9 | 0 | 3 |
| Spontaneous Conception during In Vitro Fertilization prior to Embryo Transfer without the Opportunity for Preimplantation Genetic Testing | 30.9 | 0 | 3 |
| Association between testosterone, semen parameters, and live birth in men with unexplained infertility in an intrauterine insemination population | 30.9 | 0 | 3 |
| A nomogram predicting clinical pregnancy in the first fresh embryo transfer for women undergoing in vitro fertilization and intracytoplasmic sperm injection (IVF/ICSI) treatments | 30.9 | 0 | 3 |
| Virtual Reality Use in Assisted Reproductive Technology | 30.9 | 0 | 3 |
| Intrauterine insemination performance characteristics and post-processing total motile sperm count in relation to live birth for couples with unexplained infertility in a randomised, multicentre clinical trial | 30.9 | 0 | 3 |
| [Clinical outcome of in vitro fertilization or intracytoplasmic sperm injection-embryo transfer in women aged 40 years and above] | 30.9 | 0 | 3 |
| Effects of uterine adenomyosis on clinical outcomes of infertility patients treated with in vitro fertilization/intracytoplasmic sperm injection-embryo transfer (IVF/ICSI-ET) | 30.9 | 0 | 3 |
| Efficacy and safety of Dingkun pill for female infertility patients with low prognosis undergoing in vitro fertilization-embryo transfer: study protocol for a multicenter, double-blind, randomized, placebo-controlled trial | 30.9 | 0 | 3 |
| Intracytoplasmic sperm injection (ICSI) for non-male factor indications: a committee opinion | 30.9 | 0 | 3 |
| IVM Survey Among Reproductive Medicine Specialists | 30.9 | 0 | 3 |
| Comparison of outcomes in intrauterine insemination, in vitro fertilisation and intracytoplasmic sperm injection in men with and without varicocele | 30.9 | 0 | 3 |
| Endometrial thickness after ovarian stimulation with gonadotropin, clomiphene, or letrozole for unexplained infertility, and association with treatment outcomes | 30.9 | 0 | 3 |
| Follicular fluid anti-Müllerian hormone (AMH) concentrations and outcomes of in vitro fertilization cycles with fresh embryo transfer among women at a fertility center | 30.9 | 0 | 3 |
| Short-term weight change and live birth among women with unexplained infertility and polycystic ovary syndrome undergoing ovulation induction | 30.9 | 0 | 3 |
| Follicular fluid estradiol is an improved predictor of in vitro fertilization/intracytoplasmic sperm injection and embryo transfer outcomes | 30.9 | 0 | 3 |
| Higher efficiency of frozen embryo transfer in male infertility cases in in vitro fertilization | 30.9 | 0 | 3 |
| Double-in vitro maturation increases the number of vitrified oocytes available for fertility preservation when ovarian stimulation is unfeasible | 30.9 | 0 | 3 |
| Should couples with unexplained infertility have three to six cycles of intrauterine insemination with ovarian stimulation or in vitro fertilization as first-line treatment? | 30.9 | 0 | 3 |
| [Impact of sperm DNA fragmentation on the outcome of frozen-thawed blastocyst transfer in in vitro fertilization and embryo transfer] | 30.9 | 0 | 3 |
| Do in vitro fertilization, intrauterine insemination or female infertility impact the risk of congenital anomalies in singletons? A longitudinal national French study | 30.9 | 0 | 3 |
| Maximal Endometrial Thickness (ET) Correlates With Pregnancy Rates (PR) in In Vitro Fertilization (IVF) and Ovulation Induction/Intrauterine Insemination (IUI) Cycles | 30.9 | 0 | 3 |
| Pregnancy rates following single euploid embryo transfer are unchanged in gestational carrier compared to non-gestational carrier in vitro fertilization cycles | 30.9 | 0 | 3 |
| Pregnancy outcomes following in vitro fertilization frozen embryo transfer (IVF-FET) with or without preimplantation genetic testing for aneuploidy (PGT-A) in women with recurrent pregnancy loss (RPL): a sart-cors study | 30.9 | 0 | 3 |
| Preimplantation genetic testing (PGT) and frozen embryo transfer (FET) synergistically decrease pre-term delivery in patients undergoing in vitro fertilization (IVF) | 30.9 | 0 | 3 |
| Effects of Luteinizing Hormone Supplementation on Ovarian Response and Assisted Reproductive Technology Outcomes in Antagonist In vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: A Meta-analysis | 30.9 | 0 | 3 |
| Logistic Regression Analysis of Risk Factors Associated with Spontaneous Abortion after In Vitro Fertilization/Intracytoplasmic Sperm Injection-Embryo Transfer in Polycystic Ovary Syndrome Patients | 30.9 | 0 | 3 |
| How does freeze-all strategy compare with conventional in vitro fertilization and fresh embryo transfer during assisted reproduction? | 30.9 | 0 | 3 |
| In infertile couples undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), how does embryo transfer on day three compare with embryo transfer on day two? | 30.9 | 0 | 3 |
| GYN-FIV a.s. | 30.9 | 0 | 3 |
| Successful pregnancy with restorative reproductive medicine after 16 years of infertility, three recurrent miscarriages, and eight unsuccessful embryo transfers with in vitro fertilization/intracytoplasmic sperm injection: a case report. | 30.9 | 0 | 3 |
| American Society for Reproductive Medicine | 28.9 | 1 | 1 |
| Seattle Reproductive Medicine | 28.9 | 1 | 1 |
| Reproductive Medicine Associates of New York | 28.9 | 1 | 1 |
| Reproductive Medicine Associates of New Jersey | 28.9 | 1 | 1 |
| National Institute for Occupational Safety and Health | 26.9 | 3 | 0 |
| Parents | 26.9 | 3 | 0 |
| World Immunization Week | 26.9 | 3 | 0 |
| Vital and health statistics. Series 21, Data on natality, marriage, and divorce | 26.9 | 3 | 0 |
| Vital and health statistics. Series 5, Comparative international vital and health statistics reports | 26.9 | 3 | 0 |
| World Patient Safety Day | 26.9 | 3 | 0 |
| Office of Readiness and Response | 26.9 | 3 | 0 |
| Intracytoplasmic sperm injection | 24.5 | 0 | 2 |
| Robert Edwards | 24.5 | 0 | 2 |
| in vitro fertilization | 24.5 | 0 | 2 |
| azoospermia | 24.5 | 0 | 2 |
| egg donation | 24.5 | 0 | 2 |
| preimplantation genetic diagnosis | 24.5 | 0 | 2 |
| Vitrification (ovocytes) | 24.5 | 0 | 2 |
| Journal of Assisted Reproduction and Genetics | 24.5 | 0 | 2 |
| Reproductive Medicine and Biology | 24.5 | 0 | 2 |
| Ectopic pregnancy secondary to in vitro fertilisation-embryo transfer: pathogenic mechanisms and management strategies | 24.5 | 0 | 2 |
| Semen analysis and fertility assessment in rabbits: statistical power and design considerations for toxicology studies | 24.5 | 0 | 2 |
| Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer) | 24.5 | 0 | 2 |
| Post-embryo transfer interventions for assisted reproduction technology cycles | 24.5 | 0 | 2 |
| In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction | 24.5 | 0 | 2 |
| Assisted hatching on assisted conception (in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI)) | 24.5 | 0 | 2 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 24.5 | 0 | 2 |
| Clomiphene citrate in combination with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilization | 24.5 | 0 | 2 |
| Clomiphene citrate for controlled ovarian stimulation in women undergoing in vitro fertilization | 24.5 | 0 | 2 |
| Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation | 24.5 | 0 | 2 |
| Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles | 24.5 | 0 | 2 |
| In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction | 24.5 | 0 | 2 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 24.5 | 0 | 2 |
| Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection | 24.5 | 0 | 2 |
| Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection | 24.5 | 0 | 2 |
| In vitro maturation in sub fertile patients with polycystic ovarian syndrome undergoing assisted reproduction | 24.5 | 0 | 2 |
| Ovarian stimulation protocols (anti-oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with subfertility | 24.5 | 0 | 2 |
| Soft versus firm embryo transfer catheters for assisted reproductive technology | 24.5 | 0 | 2 |
| Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles | 24.5 | 0 | 2 |
| Ovarian stimulation protocols (anti-oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with subfertility | 24.5 | 0 | 2 |
| Recombinant versus urinary derived gonadotrophins for ovarian stimulation in in vitro fertilisation and intra-cytoplasmic sperm injection cycles | 24.5 | 0 | 2 |
| Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation | 24.5 | 0 | 2 |
| The use of complementary and alternative fertility treatment in couples seeking fertility care: data from a prospective cohort in the United States | 24.5 | 0 | 2 |
| Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial | 24.5 | 0 | 2 |
| Human chorionic gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination | 24.5 | 0 | 2 |
| First successful case of in vitro fertilization-embryo transfer with venom immunotherapy for hymenoptera sting allergy | 24.5 | 0 | 2 |
| Monochorionic-triamniotic triplet pregnancy after intracytoplasmic sperm injection, assisted hatching, and two-embryo transfer: first reported case following IVF | 24.5 | 0 | 2 |
| Journal of Experimental & Clinical Assisted Reproduction: shaping the future of research and practice in reproductive endocrinology/infertility | 24.5 | 0 | 2 |
| Low-dose aspirin does not improve ovarian stimulation, endometrial response, or pregnancy rates for in vitro fertilization | 24.5 | 0 | 2 |
| Identification and isolation of embryonic stem cells in reproductive endocrinology: theoretical protocols for conservation of human embryos derived from in vitro fertilization | 24.5 | 0 | 2 |
| The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment | 24.5 | 0 | 2 |
| Sperm maturity and treatment choice of in vitro fertilization (IVF) or intracytoplasmic sperm injection: diminished sperm HspA2 chaperone levels predict IVF failure | 24.5 | 0 | 2 |
| Cleavage stage versus blastocyst stage embryo transfer in assisted reproductive technology | 24.5 | 0 | 2 |
| Resurgence of Minimal Stimulation In Vitro Fertilization with A Protocol Consisting of Gonadotropin Releasing Hormone-Agonist Trigger and Vitrified-Thawed Embryo Transfer | 24.5 | 0 | 2 |
| A Review of The Society for Assisted Reproductive Technology Embryo Grading System and Proposed Modification | 24.5 | 0 | 2 |
| Surgery for endometriosis-associated infertility: do we exaggerate the magnitude of effect? | 24.5 | 0 | 2 |
| The evaluation of pre and post processing semen analysis parameters at the time of intrauterine insemination in couples diagnosed with male factor infertility and pregnancy rates based on stimulation agent. A retrospective cohort study | 24.5 | 0 | 2 |
| The prognostic profile of subfertile couples and treatment outcome after expectant management, intrauterine insemination and in vitro fertilisation: a study protocol for the meta-analysis of individual patient data | 24.5 | 0 | 2 |
| Effectiveness of GnRH Antagonist in the Management of Subfertile Couples Undergoing Controlled Ovarian Stimulation and Intrauterine Insemination: A Meta-Analysis | 24.5 | 0 | 2 |
| Journal of in vitro fertilization and embryo transfer : IVF | 24.5 | 0 | 2 |
| Journal of fertilization. In vitro IVF worldwide reproductive medicine genetics & stem cell biology | 24.5 | 0 | 2 |
| Abdominal ectopic pregnancy after in vitro fertilization and single embryo transfer: a case report and systematic review | 24.5 | 0 | 2 |
| Debating Elective Single Embryo Transfer after in vitro Fertilization: A Plea for a Context-Sensitive Approach | 24.5 | 0 | 2 |
| Examining the evidence: progesterone supplementation during fresh and frozen embryo transfer | 24.5 | 0 | 2 |
| Hysteroscopic cervical canal shaving: a new therapy for cervical stenosis before embryo transfer in patients undergoing in vitro fertilization | 24.5 | 0 | 2 |
| Does addition of low-dose aspirin and/or steroid as a standard treatment in nonselected intracytoplasmic sperm injection cycles improve in vitro fertilization success? A randomized, prospective, placebo-controlled study | 24.5 | 0 | 2 |
| Effects of co-administration of growth hormone(GH) and aspirin to women during in vitro fertilization and embryo transfer (IVF-ET) cycles | 24.5 | 0 | 2 |
| Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: potential fertility preservation for female cancer patients | 24.5 | 0 | 2 |
| In vitro maturation (IVM) of oocytes recovered from ovariectomy specimens in the laboratory: a promising "ex vivo" method of oocyte cryopreservation resulting in the first report of an ongoing pregnancy in Europe | 24.5 | 0 | 2 |
| Similarin vitromaturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients | 24.5 | 0 | 2 |
| Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis | 24.5 | 0 | 2 |
| Serum progestagen-associated endometrial protein (PEP) levels in conception versus nonconception cycles following in vitro fertilization-embryo transfer | 24.5 | 0 | 2 |
| Q28344605 | 24.5 | 0 | 2 |
| Urinary bisphenol A concentrations and association within vitrofertilization outcomes among women from a fertility clinic | 24.5 | 0 | 2 |
| Urinary paraben concentrations and in vitro fertilization outcomes among women from a fertility clinic | 24.5 | 0 | 2 |
| Dietary folate intake and modification of the association of urinary bisphenol A concentrations with in vitro fertilization outcomes among women from a fertility clinic | 24.5 | 0 | 2 |
| Hair mercury concentrations and in vitro fertilization (IVF) outcomes among women from a fertility clinic | 24.5 | 0 | 2 |
| Useful Predictors of Ovarian Stimulation Response in Women Undergoing in vitro Fertilization | 24.5 | 0 | 2 |
| Worldwide prevalence of adverse pregnancy outcomes associated with in vitro fertilization/intracytoplasmic sperm injection among multiple births: a systematic review and meta-analysis based on cohort studies | 24.5 | 0 | 2 |
| Worldwide prevalence of adverse pregnancy outcomes among singleton pregnancies after in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis | 24.5 | 0 | 2 |
| Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation. | 24.5 | 0 | 2 |
| Fertility-related quality of life from two RCT cohorts with infertility: unexplained infertility and polycystic ovary syndrome. | 24.5 | 0 | 2 |
| Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility | 24.5 | 0 | 2 |
| Assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial: baseline characteristics | 24.5 | 0 | 2 |
| Predictors of participant retention in infertility treatment trials | 24.5 | 0 | 2 |
| Randomized Trial of Harp Therapy During In Vitro Fertilization–Embryo Transfer | 24.5 | 0 | 2 |
| First-trimester diagnosis and management of Cesarean scar pregnancies after in vitro fertilization-embryo transfer: a retrospective clinical analysis of 12 cases | 24.5 | 0 | 2 |
| Outcomes and Recommendations of an Indian Expert Panel for Improved Practice in Controlled Ovarian Stimulation for Assisted Reproductive Technology. | 24.5 | 0 | 2 |
| Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization. | 24.5 | 0 | 2 |
| Altering hirsutism through ovulation induction in women with polycystic ovary syndrome | 24.5 | 0 | 2 |
| Immunoregulation of follicular renewal, selection, POF, and menopause in vivo, vs. neo-oogenesis in vitro, POF and ovarian infertility treatment, and a clinical trial | 24.5 | 0 | 2 |
| Frequency of the male infertility evaluation: data from the national survey of family growth | 24.5 | 0 | 2 |
| In vitro fertilization - analysis of data in Czech National Assisted Reproduction Register from years 2007-2011 | 24.5 | 0 | 2 |
| Obligatory versus elective single embryo transfer in in vitro fertilization. A population-based analysis of data from the U.K. Human Fertilisation and Embryology Authority | 24.5 | 0 | 2 |
| Intracytoplasmic sperm injection of in vitro matured oocytes of domestic cats with frozen-thawed epididymal spermatozoa | 24.5 | 0 | 2 |
| Risk of major congenital anomalies after assisted hatching: analysis of three-year data from the national assisted reproduction registry in Japan | 24.5 | 0 | 2 |
| Laparoscopic management of hydrosalpinges before in vitro fertilization-embryo transfer: salpingectomy versus proximal tubal occlusion | 24.5 | 0 | 2 |
| Outcomes of in vitro fertilization with preimplantation genetic diagnosis: an analysis of the United States Assisted Reproductive Technology Surveillance Data, 2011-2012 | 24.5 | 0 | 2 |
| Effectiveness of in vitro fertilization with preimplantation genetic screening: a reanalysis of United States assisted reproductive technology data 2011–2012 | 24.5 | 0 | 2 |
| Could induced apoptosis of human granulosa cells predict in vitro fertilization-embryo transfer outcome? A preliminary study of 25 women. | 24.5 | 0 | 2 |
| Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix | 24.5 | 0 | 2 |
| A prospective randomized clinical trial of differing starter doses of recombinant follicle-stimulating hormone (follitropin-beta) for first time in vitro fertilization and intracytoplasmic sperm injection treatment cycles | 24.5 | 0 | 2 |
| Impact of intramural leiomyomata in patients with a normal endometrial cavity on in vitro fertilization-embryo transfer cycle outcome | 24.5 | 0 | 2 |
| Value of the serum estradiol level on the day of human chorionic gonadotropin injection and on the day after in predicting the outcome in natural in vitro fertilization/intracytoplasmic sperm injection cycles | 24.5 | 0 | 2 |
| No arguments to support an age limit for men entering an in vitro fertilisation or intracytoplasmic sperm injection programme | 24.5 | 0 | 2 |
| Risk assessment of mouse hepatitis virus infection via in vitro fertilization and embryo transfer by the use of zona-intact and laser-microdissected oocytes | 24.5 | 0 | 2 |
| Pregnancy outcomes after assisted reproductive technology | 24.5 | 0 | 2 |
| Laser assisted hatching in good prognosis patients undergoing in vitro fertilization-embryo transfer: a randomized controlled trial | 24.5 | 0 | 2 |
| Human spermatozoa ultrastructure assessment in the infertility treatment by assisted reproduction technique | 24.5 | 0 | 2 |
| The influence of the number of follicles on pregnancy rates in intrauterine insemination with ovarian stimulation: a meta-analysis. | 24.5 | 0 | 2 |
| Fertility clinic, egg donation agency, and sperm bank policies | 24.5 | 0 | 2 |
| Advances in microsurgery and assisted reproduction for management of male infertility | 24.5 | 0 | 2 |
| Primate Follicular Development and Oocyte Maturation In Vitro | 24.5 | 0 | 2 |
| Increasing and decreasing factors of hope in infertile women with failure in infertility treatment: A phenomenology study | 24.5 | 0 | 2 |
| The status of assisted reproductive technology in Korea in 2012 | 24.5 | 0 | 2 |
| The impact of atosiban on pregnancy outcomes in women undergoing in vitro fertilization-embryo transfer: A meta-analysis | 24.5 | 0 | 2 |
| Elective single embryo transfer following in vitro fertilization | 24.5 | 0 | 2 |
| Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis. | 24.5 | 0 | 2 |
| Role of perifollicular Doppler blood flow in predicting cycle response in infertile women with genital tuberculosis undergoing in vitro fertilization/intracytoplasmic sperm injection | 24.5 | 0 | 2 |
| Fertility Preservation in Cancer Patients: In Vivo and In Vitro Options | 24.5 | 0 | 2 |
| Fertility treatments and outcomes among couples seeking fertility care: data from a prospective fertility cohort in the United States | 24.5 | 0 | 2 |
| Efficiency of metaphase II oocytes following minimal/mild ovarian stimulation in vitro fertilization | 24.5 | 0 | 2 |
| Analysis of oocyte cryopreservation in assisted reproduction: the Italian National Register data from 2005 to 2007 | 24.5 | 0 | 2 |
| Impacts of Anti-dsDNA Antibody on In Vitro Fertilization-Embryo Transfer and Frozen-Thawed Embryo Transfer. | 24.5 | 0 | 2 |
| The efficacy and adverse effects of in vitro fertilization and embryo transfer | 24.5 | 0 | 2 |
| In vitro fertilization by intracytoplasmic sperm injection | 24.5 | 0 | 2 |
| Endometrial injury, the quality of embryos, and blastocyst transfer are the most important prognostic factors for in vitro fertilization success after previous repeated unsuccessful attempts | 24.5 | 0 | 2 |
| GnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer in fresh cycles | 24.5 | 0 | 2 |
| Blastocyst culture and transfer: analysis of results and parameters affecting outcome in two in vitro fertilization programs | 24.5 | 0 | 2 |
| Combined analysis of endometrial thickness and pattern in predicting outcome of in vitro fertilization and embryo transfer: a retrospective cohort study | 24.5 | 0 | 2 |
| Ovarian stimulation for in-vitro fertilization/intracytoplasmic sperm injection with gonadotrophins and gonadotrophin-releasing hormone analogues: agonists and antagonists | 24.5 | 0 | 2 |
| The impact of letrozole versus clomiphene citrate on uterine blood flow in patients with unexplained infertility | 24.5 | 0 | 2 |
| Progesterone rise on the day of HCG administration (premature luteinization) in IVF: An overdue update | 24.5 | 0 | 2 |
| Corifollitropin alfa compared to daily rFSH or HP-HMG in GnRH antagonist controlled ovarian stimulation protocol for patients undergoing assisted reproduction. | 24.5 | 0 | 2 |
| Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome | 24.5 | 0 | 2 |
| Cellular and molecular events after in vitro fertilization and intracytoplasmic sperm injection | 24.5 | 0 | 2 |
| Women's perceptions and experiences of the challenges in the process of male infertility treatment: A qualitative study. | 24.5 | 0 | 2 |
| The incidence of monozygotic twinning in assisted reproductive technology: Analysis based on results from the 2010 Japanese ART national registry | 24.5 | 0 | 2 |
| The Photosensitivity Localized in a Vitiliginous Lesion Was Associated with the Intramuscular Injections of Synthetic Progesterone during an In Vitro Fertilization-embryo Transfer | 24.5 | 0 | 2 |
| Follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in assisted reproduction cycles | 24.5 | 0 | 2 |
| A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T) | 24.5 | 0 | 2 |
| Minimal precycle testing and ongoing cycle monitoring for in vitro fertilization and fresh pre-embryo transfer do not compromise fertilization, implantation, or ongoing pregnancy rates | 24.5 | 0 | 2 |
| Comparison of clinical outcomes between fresh embryo transfers and frozen-thawed embryo transfers | 24.5 | 0 | 2 |
| Does prayer influence the success of in vitro fertilization-embryo transfer? Report of a masked, randomized trial. | 24.5 | 0 | 2 |
| In vitro manipulation of nonhuman primate gametes for embryo production and embryo transfer | 24.5 | 0 | 2 |
| Recent Progress in Pharmacological Therapy of Male Subfertility - a Review* | 24.5 | 0 | 2 |
| Three-Day-Old Human Unfertilized Oocytes after In Vitro Fertilization/Intracytoplasmic Sperm Injection Can Be Activated by Calcium Ionophore A23187 or Strontium Chloride and Develop to Blastocysts | 24.5 | 0 | 2 |
| Phytoestrogens may improve the pregnancy rate in in vitro fertilization-embryo transfer cycles: a prospective, controlled, randomized trial | 24.5 | 0 | 2 |
| Cost-effectiveness analysis comparing continuation of assisted reproductive technology with conversion to intrauterine insemination in patients with low follicle numbers | 24.5 | 0 | 2 |
| The role of gonadotropins in follicular development and their use in ovulation induction protocols for assisted reproduction | 24.5 | 0 | 2 |
| Does the Ovarian Stimulation Phase Length Predict In vitro Fertilization Outcomes? | 24.5 | 0 | 2 |
| Contemporary approach to the male infertility evaluation | 24.5 | 0 | 2 |
| Ovarian reserve tests and their utility in predicting response to controlled ovarian stimulation in rhesus monkeys | 24.5 | 0 | 2 |
| Ovarian stimulation medications and patients' responses as prognostic factors in IUI-treated infertile Saudi patients | 24.5 | 0 | 2 |
| Evaluation of clinical factors influencing pregnancy rate in frozen embryo transfer | 24.5 | 0 | 2 |
| Effect of male hepatitis B virus infection on outcomes of in vitro fertilization and embryo transfer treatment: insights from couples undergoing oocyte donation | 24.5 | 0 | 2 |
| Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles. | 24.5 | 0 | 2 |
| Predictive value of plasma human chorionic gonadotrophin beta subunit in diagnosing ectopic pregnancy after in vitro fertilisation and embryo transfer | 24.5 | 0 | 2 |
| Impact of short-term preconceptional exposure to particulate air pollution on treatment outcome in couples undergoing in vitro fertilization and embryo transfer (IVF/ET) | 24.5 | 0 | 2 |
| Genetically determined male infertility and assisted reproduction techniques | 24.5 | 0 | 2 |
| Adnexal Torsion during Pregnancy after Oocyte In Vitro Maturation and Intracytoplasmic Sperm Injection Cycle | 24.5 | 0 | 2 |
| How the FMR1 gene became relevant to female fertility and reproductive medicine | 24.5 | 0 | 2 |
| Single-donor and double-donor sperm intrauterine insemination cycles: does double intrauterine insemination increase clinical pregnancy rates? | 24.5 | 0 | 2 |
| Fertility preservation outcomes may differ by cancer diagnosis | 24.5 | 0 | 2 |
| Term delivery following pyometra after in vitro fertilization and embryo transfer | 24.5 | 0 | 2 |
| In vitro technologies related to pig embryo transfer. | 24.5 | 0 | 2 |
| Successful pregnancy in a 42-year-old woman with imminent ovarian failure following ovulation induction with ethinyl estradiol without gonadotropins and in vitro fertilization | 24.5 | 0 | 2 |
| Eight-hydroxy-2'-deoxyguanosine in granulosa cells is correlated with the quality of oocytes and embryos in an in vitro fertilization-embryo transfer program | 24.5 | 0 | 2 |
| Minimal ovarian stimulation (mini-IVF) for IVF utilizing vitrification and cryopreserved embryo transfer | 24.5 | 0 | 2 |
| Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature | 24.5 | 0 | 2 |
| Oocyte cryopreservation: a feasible fertility preservation option for reproductive age cancer survivors. | 24.5 | 0 | 2 |
| Maternal age and initial β-hCG levels predict pregnancy outcome after single vitrified-warmed blastocyst transfer | 24.5 | 0 | 2 |
| The outcome of infertility treatment in patients undergoing assisted reproductive technology after conservative therapy for endometrial cancer | 24.5 | 0 | 2 |
| Predictors of not pursuing infertility treatment after an infertility diagnosis: examination of a prospective U.S. cohort | 24.5 | 0 | 2 |
| Male infertility and intracytoplasmic sperm injection (ICSI). | 24.5 | 0 | 2 |
| The future of male infertility management and assisted reproduction technology | 24.5 | 0 | 2 |
| Fertility treatment in women with polycystic ovary syndrome: a decision analysis of different oral ovulation induction agents | 24.5 | 0 | 2 |
| The breadth of in vitro fertilization and embryo transfer | 24.5 | 0 | 2 |
| Delivery after intrauterine embryo transfer obtained by fertilization and oocyte culture in vitro | 24.5 | 0 | 2 |
| Efficacy of the local endometrial injury in patients who had previous failed IVF-ICSI outcome | 24.5 | 0 | 2 |
| An overview of male infertility in the era of intracytoplasmic sperm injection | 24.5 | 0 | 2 |
| Assisted hatching and intracytoplasmic sperm injection are not associated with improved outcomes in assisted reproduction cycles for diminished ovarian reserve: an analysis of cycles in the United States from 2004 to 2011. | 24.5 | 0 | 2 |
| Cornual heterotopic pregnancy and cornual resection after in vitro fertilization/embryo transfer. A report of two cases | 24.5 | 0 | 2 |
| Intracytoplasmic sperm injection facilitates fertilization even in the most severe forms of male infertility: pregnancy outcome correlates with maternal age and number of eggs available. | 24.5 | 0 | 2 |
| Parameters that predict success for natural cycle in vitro fertilization-embryo transfer | 24.5 | 0 | 2 |
| Empirical medical therapy in idiopathic male infertility: Promise or panacea? | 24.5 | 0 | 2 |
| Is tubal embryo transfer of any value? A meta-analysis and comparison with the Society for Assisted Reproductive Technology database | 24.5 | 0 | 2 |
| Obesity is not associated with the poor pregnancy outcome following intracytoplasmic sperm injection in women with polycystic ovary syndrome | 24.5 | 0 | 2 |
| Endometrial thickness affects the outcome of in vitro fertilization and embryo transfer in normal responders after GnRH antagonist administration | 24.5 | 0 | 2 |
| Use of third generation gonadotropin-releasing hormone antagonists in in vitro fertilization-embryo transfer: a review | 24.5 | 0 | 2 |
| Subcutaneous progesterone versus vaginal progesterone gel for luteal phase support in in vitro fertilization: a noninferiority randomized controlled study | 24.5 | 0 | 2 |
| Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis | 24.5 | 0 | 2 |
| Efficacy and safety of long-acting GnRH agonists in in vitro fertilization and embryo transfer. | 24.5 | 0 | 2 |
| The antral follicle count is a better marker than basal follicle-stimulating hormone for the selection of older patients with acceptable pregnancy prospects after in vitro fertilization | 24.5 | 0 | 2 |
| Gene expression and DNA-methylation of bovine pretransfer endometrium depending on its receptivity after in vitro-produced embryo transfer | 24.5 | 0 | 2 |
| Risk of thrombosis in women with malignancies undergoing ovarian stimulation for fertility preservation | 24.5 | 0 | 2 |
| Fresh embryo transfer versus frozen embryo transfer in in vitro fertilization cycles: a systematic review and meta-analysis | 24.5 | 0 | 2 |
| Three protocols for monitoring follicle development in 587 unstimulated cycles of in vitro fertilization and intracytoplasmic sperm injection. A comparison. | 24.5 | 0 | 2 |
| Mitochondrial replacement therapy in reproductive medicine | 24.5 | 0 | 2 |
| Surgery or assisted reproduction? A decision analysis of treatment costs in male infertility | 24.5 | 0 | 2 |
| Age, body mass index, and number of previous trials: are they prognosticators of intra-uterine-insemination for infertility treatment? | 24.5 | 0 | 2 |
| Births of normal daughters after MicroSort sperm separation and intrauterine insemination, in-vitro fertilization, or intracytoplasmic sperm injection | 24.5 | 0 | 2 |
| Percutaneous testicular sperm aspiration: a convenient and effective office procedure to retrieve sperm for in vitro fertilization with intracytoplasmic sperm injection | 24.5 | 0 | 2 |
| Factors influencing pregnancy rates with a combined clomiphene citrate/gonadotropin protocol for non-assisted reproductive technology fertility treatment | 24.5 | 0 | 2 |
| Prediction of clinical pregnancy in vitrified-warmed single blastocyst transfer cycles by pre-freeze morphology | 24.5 | 0 | 2 |
| Marked improvement in clinical pregnancy rates following in vitro fertilization-embryo transfer seen when transfer technique and catheter were changed. | 24.5 | 0 | 2 |
| Large offspring syndrome and other consequences of ruminant embryo culture in vitro: relevance to blastocyst culture in human ART. | 24.5 | 0 | 2 |
| Impaired glucose metabolism in response to high fat diet in female mice conceived by in vitro fertilization (IVF) or ovarian stimulation alone | 24.5 | 0 | 2 |
| Infertility evaluation via laparoscopy and hysteroscopy after conservative treatment for tubal pregnancy | 24.5 | 0 | 2 |
| Live birth sex ratio after in vitro fertilization and embryo transfer in China--an analysis of 121,247 babies from 18 centers | 24.5 | 0 | 2 |
| Effect of glucose concentration during in vitro culture of mouse embryos on development to blastocyst, success of embryo transfer, and litter sex ratio | 24.5 | 0 | 2 |
| Assisted reproduction and reproductive rights: the case of in vitro fertilization | 24.5 | 0 | 2 |
| Estradiol progesterone ratio on ovulation induction day: a determinant of successful pregnancy outcome after intra cytoplasmic sperm injection | 24.5 | 0 | 2 |
| Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction | 24.5 | 0 | 2 |
| Intracytoplasmic Sperm Injection (ICSI) in Extreme Cases of Male Infertility | 24.5 | 0 | 2 |
| Follicular fluid Aβ40 concentrations may be associated with ongoing pregnancy following in vitro fertilization | 24.5 | 0 | 2 |
| Reproductive medicine 2014: the year in review | 24.5 | 0 | 2 |
| Does IVF cleavage stage embryo quality affect pregnancy complications and neonatal outcomes in singleton gestations after double embryo transfers? | 24.5 | 0 | 2 |
| Concurrent ovarian and ipsilateral tubal ectopic pregnancies after a double embryo transfer: a case report | 24.5 | 0 | 2 |
| Oocyte Cryopreservation for Fertility Preservation in Postpubertal Female Children at Risk for Premature Ovarian Failure Due to Accelerated Follicle Loss in Turner Syndrome or Cancer Treatments | 24.5 | 0 | 2 |
| Deep intrauterine insemination and embryo transfer in pigs. | 24.5 | 0 | 2 |
| In vitro fertilisation and embryo transfer for bilateral salpingectomies results in a ruptured ovarian ectopic pregnancy due to a tubal stump fistula: a case report and review of the literature | 24.5 | 0 | 2 |
| Effect of ethnicity on live birth rates after in vitro fertilisation or intracytoplasmic sperm injection treatment. | 24.5 | 0 | 2 |
| Recombinant luteinizing hormone supplementation in women undergoing in vitro fertilization/ intracytoplasmic sperm injection with gonadotropin releasing hormone antagonist protocol: a systematic review and meta-analysis | 24.5 | 0 | 2 |
| Interstitial pregnancy after in vitro fertilization and embryo transfer following bilateral salpingectomy: report of two cases and literature review | 24.5 | 0 | 2 |
| Access to fertility treatment by gays, lesbians, and unmarried persons: a committee opinion | 24.5 | 0 | 2 |
| Do polymorphic variants of chromosomes affect the outcome of in vitro fertilization and embryo transfer treatment? | 24.5 | 0 | 2 |
| Treatment-independent pregnancy after in vitro fertilization and embryo transfer trial | 24.5 | 0 | 2 |
| Role of baseline antral follicle count and anti-Mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort analysis. | 24.5 | 0 | 2 |
| Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated with diminished ovarian reserve | 24.5 | 0 | 2 |
| Effect of Sperm Count on Success of Intrauterine Insemination in Couples Diagnosed with Male Factor Infertility | 24.5 | 0 | 2 |
| Bilateral ovarian pregnancy after intrauterine insemination and controlled ovarian stimulation | 24.5 | 0 | 2 |
| The Effect of Single Embryo Transfer on Perinatal Outcomes in Japan | 24.5 | 0 | 2 |
| Uncomplicated pregnancy and normal singleton delivery after surgical excision of heterotopic (cornual) pregnancy following in vitro fertilization/embryo transfer | 24.5 | 0 | 2 |
| Association of assisted reproductive technology (ART) treatment and parental infertility diagnosis with autism in ART-conceived children | 24.5 | 0 | 2 |
| Monozygotic twinning is not increased after single blastocyst transfer compared with single cleavage-stage embryo transfer. | 24.5 | 0 | 2 |
| Intrauterine insemination with or without mild ovarian stimulation in couples with male subfertility due to oligo/astheno- and/or teratozoospermia or antisperm antibodies: a prospective cross-over trial. | 24.5 | 0 | 2 |
| Morphokinetic analysis of cleavage stage embryos and its relationship to aneuploidy in a retrospective time-lapse imaging study | 24.5 | 0 | 2 |
| The clinical outcomes of day 3 4-cell embryos after extended in vitro culture | 24.5 | 0 | 2 |
| A healthy delivery of twins by assisted reproduction followed by preimplantation genetic screening in a woman with X-linked dominant incontinentia pigmenti | 24.5 | 0 | 2 |
| Gonadotrophins: The future | 24.5 | 0 | 2 |
| Two interesting cases of ovarian pregnancy after in vitro fertilization-embryo transfer and its successful laparoscopic management | 24.5 | 0 | 2 |
| Duration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial | 24.5 | 0 | 2 |
| Fertility treatment when the prognosis is very poor or futile | 24.5 | 0 | 2 |
| Access to fertility treatment by gays, lesbians, and unmarried persons | 24.5 | 0 | 2 |
| Studies on male infertility--acrosome reaction of the human sperm incubated in vitro | 24.5 | 0 | 2 |
| High-response intrauterine insemination cycles converted to low-cost in vitro fertilization | 24.5 | 0 | 2 |
| In vitro production of bovine embryos and their application for embryo transfer | 24.5 | 0 | 2 |
| What the urologist should know about the female infertility evaluation | 24.5 | 0 | 2 |
| Live birth after in vitro fertilization and single embryo transfer in a kidney transplant patient: a case report and review of the literature | 24.5 | 0 | 2 |
| Can hyaluronan binding assay predict the outcome of intrauterine insemination in couples with unexplained or mild male factor infertility? | 24.5 | 0 | 2 |
| Hysteroscopy prior to the first IVF cycle: A systematic review and meta-analysis | 24.5 | 0 | 2 |
| Male infertility and copy number variants (CNVs) in the dog: a two-pronged approach using Computer Assisted Sperm Analysis (CASA) and Fluorescent In Situ Hybridization (FISH). | 24.5 | 0 | 2 |
| Thirteen -weeks ovarian pregnancy following in vitro fertilization for primary infertility treatment: A case report | 24.5 | 0 | 2 |
| Extended letrozole regimen versus clomiphene citrate for superovulation in patients with unexplained infertility undergoing intrauterine insemination: a randomized controlled trial | 24.5 | 0 | 2 |
| Ovarian stimulation in patients with breast cancer | 24.5 | 0 | 2 |
| Effects of Liuwei Dihuang Granule ([symbols; see text]) on the outcomes of in vitro fertilization pre-embryo transfer in infertility women with Kidney-yin deficiency syndrome and the proteome expressions in the follicular fluid. | 24.5 | 0 | 2 |
| Outcomes with intracytoplasmic sperm injection of cryopreserved sperm from men with spinal cord injury | 24.5 | 0 | 2 |
| Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients | 24.5 | 0 | 2 |
| Fertilization abnormalities following human in vitro fertilization and intracytoplasmic sperm injection | 24.5 | 0 | 2 |
| Effect of single embryo transfer on the risk of preterm birth associated with in vitro fertilization | 24.5 | 0 | 2 |
| Manipulation and in vitro maturation of Xenopus laevis oocytes, followed by intracytoplasmic sperm injection, to study embryonic development | 24.5 | 0 | 2 |
| The comparison between Intrauterine Insemination and Fallopian Tube Sperm Perfusion Using FAST®System in Patients with Unexplained Infertility | 24.5 | 0 | 2 |
| Surgical treatment of male infertility in the era of intracytoplasmic sperm injection – new insights | 24.5 | 0 | 2 |
| Anti-Mullerian hormone and antral follicle count as predictors for embryo/oocyte cryopreservation cycle outcomes in breast cancer patients stimulated with letrozole and follicle stimulating hormone | 24.5 | 0 | 2 |
| The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment? | 24.5 | 0 | 2 |
| Short-term luteinizing hormone-releasing hormone agonist treatment: prospective trial of a novel ovarian stimulation regimen for in vitro fertilization | 24.5 | 0 | 2 |
| The case for initial treatment with intrauterine insemination as opposed to in vitro fertilization for idiopathic infertility | 24.5 | 0 | 2 |
| Hospital mental health admissions in women after unsuccessful infertility treatment and in vitro fertilization: an Australian population-based cohort study | 24.5 | 0 | 2 |
| The use of luteinising hormone releasing hormone agonists for ovarian stimulation in assisted reproductive technology | 24.5 | 0 | 2 |
| Ovarian stimulation and low birth weight in newborns conceived through in vitro fertilization | 24.5 | 0 | 2 |
| Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience | 24.5 | 0 | 2 |
| Monochorionic triamniotic triplets following conventional in vitro fertilization and blastocyst transfer | 24.5 | 0 | 2 |
| Children conceived by in vitro fertilisation after fresh embryo transfer | 24.5 | 0 | 2 |
| Normal epigenetic inheritance in mice conceived by in vitro fertilization and embryo transfer | 24.5 | 0 | 2 |
| Trophectoderm morphology predicts outcomes of pregnancy in vitrified-warmed single-blastocyst transfer cycle in a Chinese population | 24.5 | 0 | 2 |
| Comparison of the effect of different media on the clinical outcomes of the density-gradient centrifugation/swim-up and swim-up methods | 24.5 | 0 | 2 |
| Successful Delivery Following Staphylococcus aureus Bacteremia after In Vitro Fertilization and Embryo Transfer | 24.5 | 0 | 2 |
| Ovulation induction in in vitro fertilization | 24.5 | 0 | 2 |
| The outcomes of intracytoplasmic sperm injection and laser assisted hatching in women undergoing in vitro fertilization are affected by the cause of infertility | 24.5 | 0 | 2 |
| Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort | 24.5 | 0 | 2 |
| A Case of Pregnancy Complicated by the Development of a Tubo-ovarian Abscess Following In Vitro Fertilization and Embryo Transfer | 24.5 | 0 | 2 |
| Does surgical management of endometriosis within 6 months of an in vitro fertilization-embryo transfer cycle improve outcome? | 24.5 | 0 | 2 |
| Assisted conception. II--in vitro fertilisation and intracytoplasmic sperm injection | 24.5 | 0 | 2 |
| Application of a validated prediction model for in vitro fertilization: comparison of live birth rates and multiple birth rates with 1 embryo transferred over 2 cycles vs 2 embryos in 1 cycle | 24.5 | 0 | 2 |
| Cost and safety of assisted reproductive technologies for human immunodeficiency virus-1 discordant couples | 24.5 | 0 | 2 |
| Thromboembolism after ovarian stimulation: successful management of a woman with superior sagittal sinus thrombosis after IVF and embryo transfer: Case report | 24.5 | 0 | 2 |
| In vitro fertilization and embryo transfer outcomes in relation to myometrial thickness. | 24.5 | 0 | 2 |
| Choice of ovarian stimulation regimens in assisted reproduction: finding the thread in the gonadotropin maze | 24.5 | 0 | 2 |
| Live birth rates using conventional in vitro fertilization compared to intracytoplasmic sperm injection in Bologna poor responders with a single oocyte retrieved. | 24.5 | 0 | 2 |
| Laparoscopic excision of ovarian endometrioma does not exert a qualitative effect on ovarian function: insights from in vitro fertilization and single embryo transfer cycles | 24.5 | 0 | 2 |
| Noninvasive Digital Detection of Fetal DNA in Plasma of 4-Week-Pregnant Women following In Vitro Fertilization and Embryo Transfer | 24.5 | 0 | 2 |
| Ovarian stimulation for emergency fertility preservation in cancer patients: A case series study | 24.5 | 0 | 2 |
| Pregnancy-related complications and adverse pregnancy outcomes in multiple pregnancies resulting from assisted reproductive technology: a meta-analysis of cohort studies | 24.5 | 0 | 2 |
| Effect of infertility treatment and pregnancy-related hormones on breast cell proliferation in vitro | 24.5 | 0 | 2 |
| Combined strategy for fertility preservation in an oncologic patient: vitrification of in vitro matured oocytes and ovarian tissue freezing | 24.5 | 0 | 2 |
| Comparison of obstetric outcomes in twin pregnancies after in vitro fertilization, ovarian stimulation and spontaneous conception | 24.5 | 0 | 2 |
| Intrauterine insemination: a UK survey on the adherence to NICE clinical guidelines by fertility clinics | 24.5 | 0 | 2 |
| Short-Term PTEN Inhibition Improves In Vitro Activation of Primordial Follicles, Preserves Follicular Viability, and Restores AMH Levels in Cryopreserved Ovarian Tissue From Cancer Patients | 24.5 | 0 | 2 |
| Embryonic development in human oocytes fertilized by split insemination | 24.5 | 0 | 2 |
| Deficiencies in reporting results of lesbians and gays after donor intrauterine insemination and assisted reproductive technology treatments: a review of the first emerging studies | 24.5 | 0 | 2 |
| Relationship between Antithyroid Antibody and Pregnancy Outcome following in Vitro Fertilization and Embryo Transfer | 24.5 | 0 | 2 |
| Optimal timing for elective egg freezing | 24.5 | 0 | 2 |
| Single vitrified blastocyst transfer maximizes liveborn children per embryo while minimizing preterm birth | 24.5 | 0 | 2 |
| Serum estradiol/progesterone ratio on day of embryo transfer may predict reproductive outcome following controlled ovarian hyperstimulation and in vitro fertilization | 24.5 | 0 | 2 |
| What is the most relevant standard of success in assisted reproduction?: challenges in measuring and reporting success rates for assisted reproductive technology treatments: what is optimal? | 24.5 | 0 | 2 |
| The Role of Overweight and Obesity in In Vitro Fertilization Outcomes of Poor Ovarian Responders | 24.5 | 0 | 2 |
| The dynamics of the vaginal microbiome during infertility therapy with in vitro fertilization-embryo transfer. | 24.5 | 0 | 2 |
| Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial | 24.5 | 0 | 2 |
| Corifollitropin alfa compared to daily FSH in controlled ovarian stimulation for in vitro fertilization: a meta-analysis | 24.5 | 0 | 2 |
| Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization | 24.5 | 0 | 2 |
| Effect of GnRH antagonists on clinical pregnancy rates in ovulation induction protocols with gonadotropins and intrauterine insemination | 24.5 | 0 | 2 |
| Impact on ICSI outcomes of adding 24 h of in vitro culture before testicular sperm freezing: a retrospective study | 24.5 | 0 | 2 |
| Predictive value of age-specific FSH levels for IVF-ET outcome in women with normal ovarian function | 24.5 | 0 | 2 |
| Association between follicular fluid levels of HMGB1 protein and outcomes in patients undergoing in vitro fertilization/intracytoplasmic sperm injection cycles | 24.5 | 0 | 2 |
| Sperm chromatin structure assay (SCSA) parameters are related to fertilization, blastocyst development, and ongoing pregnancy in in vitro fertilization and intracytoplasmic sperm injection cycles | 24.5 | 0 | 2 |
| Do increased levels of progesterone and progesterone/estradiol ratio on the day of human chorionic gonadotropin affects pregnancy outcome in long agonist protocol in fresh in vitro fertilization/intracytoplasmic sperm injection cycles? | 24.5 | 0 | 2 |
| Impact of different controlled ovarian stimulation protocols on the physical and psychological burdens in women undergoing in vitro fertilization/intra cytoplasmic sperm injection | 24.5 | 0 | 2 |
| In vitro fertilization in humans and embryo transfer | 24.5 | 0 | 2 |
| Miliary tuberculosis after in vitro fertilization and embryo transplantation | 24.5 | 0 | 2 |
| Ovarian stimulation and embryo banking for fertility preservation in a woman with severe mixed connective tissue disease: is it safe? | 24.5 | 0 | 2 |
| Efficacy of growth hormone supplementation with gonadotrophins in vitro fertilization for poor ovarian responders: an updated meta-analysis | 24.5 | 0 | 2 |
| Is ABO blood type associated with ovarian stimulation response in patients with diminished ovarian reserve? | 24.5 | 0 | 2 |
| What is the most relevant standard of success in assisted reproduction? Redefining success in the context of elective single embryo transfer: evidence, intuition and financial reality | 24.5 | 0 | 2 |
| Ovarian stimulation for in vitro fertilization in patients with endometriosis | 24.5 | 0 | 2 |
| Population pharmacokinetic modelling of Emfilermin (recombinant human leukaemia inhibitory factor, r-hLIF) in healthy postmenopausal women and in infertile patients undergoing in vitro fertilization and embryo transfer | 24.5 | 0 | 2 |
| Artificial oocyte activation in intracytoplasmic sperm injection cycles using testicular sperm in humanin vitrofertilization | 24.5 | 0 | 2 |
| Uterine abscess after ultrasound-guided ovum retrieval in an in vitro fertilization-embryo transfer program: case report and review of the literature | 24.5 | 0 | 2 |
| Single or multiple embryo transfer following in vitro fertilisation for improved neonatal outcome: a systematic review of the literature | 24.5 | 0 | 2 |
| Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer | 24.5 | 0 | 2 |
| Heterotopic pregnancy after in vitro fertilization-embryo transfer | 24.5 | 0 | 2 |
| Salpingectomy for hydrosalpinx prior to in vitro fertilization | 24.5 | 0 | 2 |
| Report on evaluation of the azoospermic male | 24.5 | 0 | 2 |
| Report on management of obstructive azoospermia | 24.5 | 0 | 2 |
| Report on varicocele and infertility | 24.5 | 0 | 2 |
| Effectiveness and treatment for unexplained infertility | 24.5 | 0 | 2 |
| The role of assisted hatching in in vitro fertilization: A review of the literature | 24.5 | 0 | 2 |
| Luteal phase ovarian stimulation following oocyte retrieval: is it helpful for poor responders? | 24.5 | 0 | 2 |
| Assisted reproductive technology and risk of adverse obstetric outcomes in dichorionic twin pregnancies: a systematic review and meta-analysis | 24.5 | 0 | 2 |
| Ovarian tissue and oocyte cryopreservation | 24.5 | 0 | 2 |
| Does measuring early basal serum follicular luteinising [correction of lutinising] hormone assist in predicting in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) outcome? | 24.5 | 0 | 2 |
| Methotrexate does not affect ovarian reserve or subsequent assisted reproductive technology outcomes | 24.5 | 0 | 2 |
| Correlation of serum Anti-Müllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patients | 24.5 | 0 | 2 |
| The best infertility treatment for vasectomized men: assisted reproduction or vasectomy reversal? | 24.5 | 0 | 2 |
| Increased risk of preterm birth in singleton pregnancies resulting from in vitro fertilization-embryo transfer or gamete intrafallopian transfer: a meta-analysis | 24.5 | 0 | 2 |
| Improved in vitro fertilization embryo quality and pregnancy rates with intracytoplasmic sperm injection of sperm from fresh testicular biopsy samples vs. frozen biopsy samples | 24.5 | 0 | 2 |
| The Maternal Cytokine and Chemokine Profile of Naturally Conceived Gestations Is Mainly Preserved duringIn VitroFertilization and Egg Donation Pregnancies | 24.5 | 0 | 2 |
| Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation | 24.5 | 0 | 2 |
| Poor centrosomal function of cat testicular spermatozoa impairs embryo development in vitro after intracytoplasmic sperm injection | 24.5 | 0 | 2 |
| Matrix metalloproteinase 2 level in human follicular fluid is a reliable marker of human oocyte maturation in in vitro fertilization and intracytoplasmic sperm injection cycles | 24.5 | 0 | 2 |
| Methylation levels at imprinting control regions are not altered with ovulation induction or in vitro fertilization in a birth cohort | 24.5 | 0 | 2 |
| Impact of estrogen-to-oocyte ratio on live birth rate in women undergoing in vitro fertilization and embryo transfer | 24.5 | 0 | 2 |
| Therapeutic maturation of endometrium in in vitro fertilization and embryo transfer | 24.5 | 0 | 2 |
| Regional clinical practice patterns in reproductive endocrinology: a collaborative transnational pilot survey of in vitro fertilization programs in the Middle East | 24.5 | 0 | 2 |
| Effect of high ovarian response on the expression of endocrine gland-derived vascular endothelial growth factor (EG-VEGF) in peri-implantation endometrium in IVF women | 24.5 | 0 | 2 |
| In vivo and in vitro decondensation of human sperm and assisted reproduction technologies | 24.5 | 0 | 2 |
| Minimal ovarian stimulation combined with elective single embryo transfer policy: age-specific results of a large, single-centre, Japanese cohort | 24.5 | 0 | 2 |
| Sperm chromatin structure assay results in Nigerian men with unexplained infertility | 24.5 | 0 | 2 |
| Pregnancy and fertilization potential of immature oocytes retrieved in intracytoplasmic sperm injection cycles | 24.5 | 0 | 2 |
| Embryo transfer practices and multiple births resulting from assisted reproductive technology: an opportunity for prevention | 24.5 | 0 | 2 |
| Comment on “The Role of Overweight and Obesity in In Vitro Fertilization Outcomes of Poor Ovarian Responders” | 24.5 | 0 | 2 |
| Doctors' Preferences for Controlled Ovarian Stimulation Protocols in Intrauterine Insemination | 24.5 | 0 | 2 |
| New strategy for in vitro activation of primordial follicles with mTOR and PI3K stimulators | 24.5 | 0 | 2 |
| Outcomes of ovarian stimulation after treatment with chemotherapy | 24.5 | 0 | 2 |
| Measurement of antral follicle count in patients undergoing in vitro fertilization treatment: results of a worldwide web-based survey | 24.5 | 0 | 2 |
| Embryo transfer following in vitro maturation and cryopreservation of oocytes recovered from antral follicles during conservative surgery for ovarian cancer | 24.5 | 0 | 2 |
| Soft versus firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis | 24.5 | 0 | 2 |
| Comparison of genome-wide and gene-specific DNA methylation between ART and naturally conceived pregnancies | 24.5 | 0 | 2 |
| Comparison of different starting gonadotropin doses (50, 75 and 100 IU daily) for ovulation induction combined with intrauterine insemination | 24.5 | 0 | 2 |
| Best Practices for Controlled Ovarian Stimulation in In Vitro Fertilization | 24.5 | 0 | 2 |
| GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET). | 24.5 | 0 | 2 |
| Relationship between cytokine concentration in serum and preovulatory follicular fluid and in vitro fertilization/intracytoplasmic sperm injection outcome | 24.5 | 0 | 2 |
| Efficacy of oxytocin antagonist infusion in improving in vitro fertilization outcomes on the day of embryo transfer: A meta-analysis | 24.5 | 0 | 2 |
| Variability in testis biopsy interpretation: implications for male infertility care in the era of intracytoplasmic sperm injection | 24.5 | 0 | 2 |
| Cabergoline for preventing ovarian hyperstimulation syndrome in women at risk undergoingin vitro fertilization/intracytoplasmic sperm injection treatment cycles: A randomized controlled study | 24.5 | 0 | 2 |
| Egg donation brokers: an analysis of agency versus in vitro fertilization clinic websites | 24.5 | 0 | 2 |
| The current status of sperm donation in assisted reproduction technology: ethical and legal considerations | 24.5 | 0 | 2 |
| Birth of rhesus monkey infant after in vitro fertilization and nonsurgical embryo transfer | 24.5 | 0 | 2 |
| A case of primary ovarian pregnancy after in vitro fertilization and embryo transfer | 24.5 | 0 | 2 |
| An open multicenter study to compare the efficacy of intraperitoneal insemination and intrauterine insemination following multiple follicular development as treatment for unexplained infertility | 24.5 | 0 | 2 |
| Comparison of the role of cervical and intrauterine insemination techniques on the incidence of multiple pregnancy after artificial insemination with donor sperm | 24.5 | 0 | 2 |
| Reduced in vitro fertilization of human oocytes correlates with raised circulating FSH levels during ovarian stimulation in normogonadotropic women downregulated with GnRH-analogues | 24.5 | 0 | 2 |
| Comparison of cryopreservation outcome following intracytoplasmic sperm injection and conventional in vitro fertilization | 24.5 | 0 | 2 |
| A successful pregnancy with in vitro fertilization and embryo transfer in an infertile woman with Kartagener's syndrome: a case report | 24.5 | 0 | 2 |
| Contamination of embryo transfer catheter and treatment outcome in in vitro fertilization | 24.5 | 0 | 2 |
| Differences in female and male perception of information and decision-making in single-embryo transfer in in vitro fertilization in Sweden | 24.5 | 0 | 2 |
| Sperm chromatin stability and its relationship with fertilization rate after intracytoplasmic sperm injection (ICSI) in an assisted reproduction program | 24.5 | 0 | 2 |
| In vitro fertilization treatment for severe male factor: a comparative study of intracytoplasmic sperm injection with testicular sperm extraction and with spermatozoa from ejaculate | 24.5 | 0 | 2 |
| Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: implications fo | 24.5 | 0 | 2 |
| Conservative management versus aspiration of functional ovarian cysts before ovarian stimulation for assisted reproduction | 24.5 | 0 | 2 |
| Autologous endometrial co-culture in patients with repeated failures of implantation after in vitro fertilization-embryo transfer | 24.5 | 0 | 2 |
| Cryopreserved sibling oocytes and intracytoplasmic sperm injection rescue unexpectedly poor fertilization in conventional in vitro fertilization | 24.5 | 0 | 2 |
| The status of controlled prospective clinical trials for efficacy of intracytoplasmic sperm injection in in vitro fertilization for non-male factor infertility | 24.5 | 0 | 2 |
| The reproductive performance of women with hypogonadotropic hypogonadism in an in vitro fertilization and embryo transfer program | 24.5 | 0 | 2 |
| An evaluation of the efficacy of in vitro fertilization with intracytoplasmic sperm injection for sperm with low hypoosmotic swelling test scores and poor morphology | 24.5 | 0 | 2 |
| Involvement of interleukin-1 and the interleukin-1 receptor antagonist in in vitro embryo development among women undergoing in vitro fertilization-embryo transfer | 24.5 | 0 | 2 |
| Early hormonal markers of pregnancy outcome after in vitro fertilization and embryo transfer | 24.5 | 0 | 2 |
| Abdominal ultrasound-guided embryo transfer improves clinical pregnancy rates after in vitro fertilization: experiences from 330 clinical investigations | 24.5 | 0 | 2 |
| Number and size of antral follicles as predictive factors in vitro fertilization and embryo transfer | 24.5 | 0 | 2 |
| Use of stimulated serum estradiol measurements for the prediction of hyperresponse to ovarian stimulation in in vitro fertilization (IVF). | 24.5 | 0 | 2 |
| Management of transient ovarian failure: Pregnancy after in vitro fertilization and intracytoplasmic sperm injection—A case report | 24.5 | 0 | 2 |
| Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF). | 24.5 | 0 | 2 |
| Two different timings of intrauterine insemination for non-male infertility | 24.5 | 0 | 2 |
| Controlled ovarian hyperstimulation adversely affects implantation following in vitro fertilization-embryo transfer | 24.5 | 0 | 2 |
| Defining women who are prone to have twins in in vitro fertilization--a necessary step towards single embryo transfer | 24.5 | 0 | 2 |
| Bilateral ovarian pregnancy after in vitro fertilization and embryo transfer in a patient with tubal factor infertility | 24.5 | 0 | 2 |
| The effect of smoking on oocyte quality and hormonal parameters of patients undergoing in vitro fertilization-embryo transfer | 24.5 | 0 | 2 |
| Prediction of pregnancy rate of in vitro fertilization and embryo transfer in women aged 40 and over with basal uterine artery pulsatility index | 24.5 | 0 | 2 |
| Late fertilization of unfertilized human oocytes in in vitro fertilization and intracytoplasmic sperm injection cycles: conventional insemination versus ICSI. | 24.5 | 0 | 2 |
| Relationship of the human cumulus-free oocyte maturational profile with in vitro outcome parameters after intracytoplasmic sperm injection | 24.5 | 0 | 2 |
| Subpopulations of human granulosa-luteal cells obtained from gonadotropin- or gonadotropin-releasing hormone agonist/gonadotropin-treated follicles in in vitro fertilization-embryo transfer cycles | 24.5 | 0 | 2 |
| Seasonal influences on in vitro fertilization and embryo transfer | 24.5 | 0 | 2 |
| Serum progesterone before and after human chorionic gonadotropin injection depends on the estradiol response to ovarian hyperstimulation during in vitro fertilization-embryo transfer cycles | 24.5 | 0 | 2 |
| Incidence and perinatal outcome of multiple pregnancies after intracytoplasmic sperm injection compared to standard in vitro fertilization | 24.5 | 0 | 2 |
| Acrosome index is not an absolute predictor of the outcome following conventional in vitro fertilization and intracytoplasmic sperm injection | 24.5 | 0 | 2 |
| Day 6 estradiol level predicts cycle cancellation among poor responder patients undergoing in vitro fertilization-embryo transfer cycles using a gonadotropin-releasing hormone agonist flare regimen | 24.5 | 0 | 2 |
| Effect of a sonographically diffusely enlarged uterus without distinct uterine masses on the outcome of in vitro fertilization-embryo transfer | 24.5 | 0 | 2 |
| Correlation of NK cell activation and inhibition markers with NK cytoxicity among women experiencing immunologic implantation failure after in vitro fertilization and embryo transfer | 24.5 | 0 | 2 |
| Hypothalamic-pituitary suppression with oral contraceptive pills does not improve outcome in poor responder patients undergoing in vitro fertilization-embryo transfer cycles | 24.5 | 0 | 2 |
| Estimation of second polar body retention rate after conventional insemination and intracytoplasmic sperm injection: in vitro observations from more than 5000 human oocytes | 24.5 | 0 | 2 |
| Combined intrauterine, tubal, and cervical pregnancies following in vitro fertilization and embryo transfer | 24.5 | 0 | 2 |
| Birth of a healthy infant after in vitro fertilization and embryo transfer in patient of total uterine prolapse | 24.5 | 0 | 2 |
| Progesterone luteal support after ovulation induction and intrauterine insemination: an updated systematic review and meta-analysis | 24.5 | 0 | 2 |
| Moderate ovarian stimulation does not increase the incidence of human embryo chromosomal abnormalities in in vitro fertilization cycles | 24.5 | 0 | 2 |
| Review of scientific contributions by the Belgian medical centers concerned with human in vitro fertilization and embryo transfer (IVF) | 24.5 | 0 | 2 |
| Impact of varying stages of endometriosis on the outcome of in vitro fertilization-embryo transfer | 24.5 | 0 | 2 |
| The antral follicle count predicts the outcome of pregnancy in a controlled ovarian hyperstimulation/intrauterine insemination program | 24.5 | 0 | 2 |
| Fertilization, embryo quality, and cryosurvival in in vitro fertilization and intracytoplasmic sperm injection cycles | 24.5 | 0 | 2 |
| Clinical significance of transvaginal color Doppler ultrasonography of the ovarian artery as a predictor of ovarian response in controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer | 24.5 | 0 | 2 |
| Prevalence of Chlamydia trachomatis immunoglobulin G antibodies in infertile women attending an in vitro fertility center | 24.5 | 0 | 2 |
| Mature oocyte retrieval during laparotomic debulking surgery following random-start controlled ovarian stimulation for fertility preservation in a patient with suspected ovarian cancer | 24.5 | 0 | 2 |
| Ovarian stimulation with human and recombinant gonadotropin – comparison of in vitro fertilization efficiency with use of time-lapse monitoring | 24.5 | 0 | 2 |
| The science behind 25 years of ovarian stimulation for in vitro fertilization | 24.5 | 0 | 2 |
| Oral ovulation induction agents combined with low-dose gonadotropin injections and intrauterine insemination: cost- and clinical effectiveness | 24.5 | 0 | 2 |
| Live birth after in vitro maturation and vitrification of immature oocytes retrieved from conventional IVF cycle: a case report | 24.5 | 0 | 2 |
| Letrozole in a low-cost in vitro fertilization protocol in intracytoplasmic sperm injection cycles for male factor infertility: A randomized controlled trial | 24.5 | 0 | 2 |
| Overt leptin response to controlled ovarian hyperstimulation negatively correlates with pregnancy outcome in in vitro fertilization--embryo transfer cycle | 24.5 | 0 | 2 |
| Micromanipulation in assisted reproductive technology: intracytoplasmic sperm injection, assisted hatching, and preimplantation genetic diagnosis | 24.5 | 0 | 2 |
| Firm embryo transfer catheters for assisted reproduction: a systematic review and meta-analysis using direct and adjusted indirect comparisons | 24.5 | 0 | 2 |
| Associations between paternal urinary phthalate metabolite concentrations and reproductive outcomes among couples seeking fertility treatment | 24.5 | 0 | 2 |
| Twin pregnancy after intracytoplasmic sperm injection in woman aged 49 using autologous oocytes by mild ovarian stimulation: a case report | 24.5 | 0 | 2 |
| Ovarian reserve markers in unexplained infertility patients treated with clomiphene citrate during intrauterine insemination | 24.5 | 0 | 2 |
| Maternal characteristics and pregnancy outcomes after assisted reproductive technology by infertility diagnosis: ovulatory dysfunction versus tubal obstruction | 24.5 | 0 | 2 |
| Efficacy of low dose hCG on oocyte maturity for ovarian stimulation in poor responder women undergoing intracytoplasmic sperm injection cycle: a randomized controlled trial | 24.5 | 0 | 2 |
| Oncofertility: a grand collaboration between reproductive medicine and oncology | 24.5 | 0 | 2 |
| Intrauterine insemination catheters for assisted reproduction: a systematic review and meta-analysis | 24.5 | 0 | 2 |
| Clustering of monozygotic twinning in IVF | 24.5 | 0 | 2 |
| Malignant transformation of endometrioma in a woman with a history of ovulation induction and in vitro fertilization | 24.5 | 0 | 2 |
| Conventional in vitro fertilization maybe yields more available embryos than intracytoplasmic sperm injection for patients with no indications for ICSI | 24.5 | 0 | 2 |
| The prevalence of positive urinary cotinine tests in Korean infertile couples and the effect of smoking on assisted conception outcomes | 24.5 | 0 | 2 |
| Altered Preconception Fatty Acid Intake Is Associated with Improved Pregnancy Rates in Overweight and Obese Women Undertaking in Vitro Fertilisation | 24.5 | 0 | 2 |
| Second-trimester heterotopic pregnancy after in vitro fertilization and embryo transfer--a case report and review of the literature. | 24.5 | 0 | 2 |
| Intracytoplasmic sperm injection--an assisted reproduction technique that should make us cautious about imprinting deregulation | 24.5 | 0 | 2 |
| Progesterone supplementation to prevent recurrent miscarriage and to reduce implantation failure in assisted reproduction cycles | 24.5 | 0 | 2 |
| Comparison of Ovarian volume and Antral follicle count with Endocrine tests for prediction of responsiveness in ovulation induction protocols | 24.5 | 0 | 2 |
| Pronuclear morphology evaluation in in vitro fertilization (IVF) / intracytoplasmic sperm injection (ICSI) cycles: a retrospective clinical review | 24.5 | 0 | 2 |
| Age-Related Normogram for Ovarian Antral Follicle Count in Women with Polycystic Ovary Syndrome and Comparison with Age Matched Controls Using Magnetic Resonance Imaging | 24.5 | 0 | 2 |
| Comparison of assisted reproductive technology outcomes in infertile women with polycystic ovary syndrome:In vitromaturation, GnRH agonist, and GnRH antagonist cycles | 24.5 | 0 | 2 |
| Human in vitro fertilization and embryo transfer | 24.5 | 0 | 2 |
| Effect of sperm entry on blastocyst development after in vitro fertilization and intracytoplasmic sperm injection — mouse model | 24.5 | 0 | 2 |
| Informing egg donors of the potential for embryonic research: a survey of consent forms from U.S. in vitro fertilization clinics | 24.5 | 0 | 2 |
| Effect of Cancer on Ovarian Function in Patients Undergoing In Vitro Fertilization for Fertility Preservation: A Reappraisal | 24.5 | 0 | 2 |
| Dairy intake in relation to in vitro fertilization outcomes among women from a fertility clinic. | 24.5 | 0 | 2 |
| Evidence that exposure to progesterone alone is a sufficient stimulus to cause a precipitous rise in the immunomodulatory protein the progesterone induced blocking factor (PIBF) | 24.5 | 0 | 2 |
| Hypertriglyceridemia-induced pancreatitis created by oral estrogen and in vitro fertilization ovulation induction | 24.5 | 0 | 2 |
| In vitro maturation of human oocytes for assisted reproduction | 24.5 | 0 | 2 |
| Preliminary data on our experience of in vitro fertilization-embryo transfer in the treatment of sterility | 24.5 | 0 | 2 |
| Improved embryo development in Japanese black cattle by in vitro fertilization using ovum pick-up plus intracytoplasmic sperm injection with dithiothreitol | 24.5 | 0 | 2 |
| Guidelines for reducing the risk of viral transmission during fertility treatment | 24.5 | 0 | 2 |
| Round spermatid nucleus injection (ROSNI). | 24.5 | 0 | 2 |
| Report on optimal evaluation of the infertile male | 24.5 | 0 | 2 |
| Effects of culture media conditions on production of eggs fertilized in vitro of embryos derived from ovary of high grade Hanwoo | 24.5 | 0 | 2 |
| In vitro maturation of germinal vesicle oocytes in stimulated intracytoplasmic sperm injection cycles | 24.5 | 0 | 2 |
| A reassessment of comparative pregnancy and implantation rates following embryo transfer in recipients vs their infertile donors also trying to conceive in the background of performing salpingectomy for hydrosalpinx. | 24.5 | 0 | 2 |
| Single thawed euploid embryo transfer improves IVF pregnancy, miscarriage, and multiple gestation outcomes and has similar implantation rates as egg donation. | 24.5 | 0 | 2 |
| Mild ovarian stimulation for in vitro fertilization: one perspective from the USA | 24.5 | 0 | 2 |
| Effect of polyvinylpyrrolidone on sperm function and early embryonic development following intracytoplasmic sperm injection in human assisted reproduction | 24.5 | 0 | 2 |
| Can cycle day 7 FSH concentration during controlled ovarian stimulation be used to guide FSH dosing for in vitro fertilization? | 24.5 | 0 | 2 |
| Use of acupuncture in female infertility and a summary of recent acupuncture studies related to embryo transfer. | 24.5 | 0 | 2 |
| Semen analysis is the cornerstone of investigation for male infertility | 24.5 | 0 | 2 |
| A logistic model to predict early pregnancy loss following in vitro fertilization based on 2601 infertility patients | 24.5 | 0 | 2 |
| The impact of patient preselection on reported IVF outcomes | 24.5 | 0 | 2 |
| Sperm midpiece apoptotic markers: impact on fertilizing potential in in vitro fertilization and intracytoplasmic sperm injection | 24.5 | 0 | 2 |
| Risk of repeated spontaneous luteinizing hormone surges in ovarian stimulation for in vitro fertilization | 24.5 | 0 | 2 |
| Computer-assisted semen analysis systems: comparison with routine evaluation and prognostic value in male fertility and assisted reproduction | 24.5 | 0 | 2 |
| Current status of assisted reproductive technology in Korea, 2011 | 24.5 | 0 | 2 |
| A case of Baller-Gerold syndrome following in vitro fertilization-embryo transfer | 24.5 | 0 | 2 |
| Intrafollicular ovarian pregnancy after ovulation induction/intrauterine insemination: pathophysiological aspects and diagnostic problems. | 24.5 | 0 | 2 |
| Some Interrelationships Between Plasma Levels of LH, FSH, Oestradiol 17β, Androgens and Semen Analysis Data in Male Infertility Patients | 24.5 | 0 | 2 |
| Economic Evaluation of In Vitro Fertilization with Embryo Transfer and Neosalpingostomy by Laparotomy or Laparoscopy | 24.5 | 0 | 2 |
| Serum anti-Müllerian hormone and inhibin B levels at ovulation triggering day can predict the number of immature oocytes retrieved in in vitro fertilization cycles | 24.5 | 0 | 2 |
| Comparison of clinical efficacy between a single administration of long-acting gonadotrophin-releasing hormone agonist (GnRHa) and daily administrations of short-acting GnRHa in in vitro fertilization-embryo transfer cycles | 24.5 | 0 | 2 |
| In vitro maturation, fertilization, embryo development & clinical outcome of human metaphase-I oocytes retrieved from stimulated intracytoplasmic sperm injection cycles | 24.5 | 0 | 2 |
| Varicocele management in the era of in vitro fertilization/intracytoplasmic sperm injection | 24.5 | 0 | 2 |
| Antral follicle count determines poor ovarian response better than anti-müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles | 24.5 | 0 | 2 |
| The predictive value of anti-Mullerian hormone on embryo quality, blastocyst development, and pregnancy rate following in vitro fertilization-embryo transfer (IVF-ET). | 24.5 | 0 | 2 |
| A novel approach to quantifying ovarian cell lipid content and lipid accumulation in vitro by confocal microscopy in lean women undergoing ovarian stimulation for in vitro fertilization (IVF). | 24.5 | 0 | 2 |
| Reluctance of medical professionals in adopting natural-cycle and minimal ovarian stimulation protocols in human clinical assisted reproduction | 24.5 | 0 | 2 |
| Does a strategy to promote shared decision-making reduce medical practice variation in the choice of either single or double embryo transfer after in vitro fertilisation? A secondary analysis of a randomised controlled trial | 24.5 | 0 | 2 |
| The correlation between endometrial thickness and outcome of in vitro fertilization and embryo transfer (IVF-ET) outcome | 24.5 | 0 | 2 |
| Random-start controlled ovarian stimulation for emergency fertility preservation in a patient with myelodysplastic syndrome: a case report | 24.5 | 0 | 2 |
| Time-lapse variables and embryo gender: a retrospective analysis of 81 live births obtained following minimal stimulation and single embryo transfer | 24.5 | 0 | 2 |
| In vitro spermatogenesis as a method to bypass pre-meiotic or post-meiotic barriers blocking the spermatogenetic process: genetic and epigenetic implications in assisted reproductive technology | 24.5 | 0 | 2 |
| A Case of Secondary Abdominal Pregnancy after in Vitro Fertilization Pre-Embryo Transfer (IVF-ET). | 24.5 | 0 | 2 |
| Polycystic ovary syndrome and maternal obesity affect oocyte size in in vitro fertilization/intracytoplasmic sperm injection cycles | 24.5 | 0 | 2 |
| Cryopreservation/transplantation of ovarian tissue and in vitro maturation of follicles and oocytes: challenges for fertility preservation | 24.5 | 0 | 2 |
| Use of letrozole in assisted reproduction: a systematic review and meta-analysis. | 24.5 | 0 | 2 |
| A review of mathematical models used to determine sperm donor limits for infertility treatment | 24.5 | 0 | 2 |
| Sperm chromatin structure assay parameters are not related to fertilization rates, embryo quality, and pregnancy rates in in vitro fertilization and intracytoplasmic sperm injection, but might be related to spontaneous abortion rates | 24.5 | 0 | 2 |
| Vitrification of in vitro matured oocytes collected from surplus ovarian medulla tissue resulting from fertility preservation of ovarian cortex tissue | 24.5 | 0 | 2 |
| A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology | 24.5 | 0 | 2 |
| Rescue in vitro fertilization using a GnRH antagonist in hyper-responders from gonadotropin intrauterine insemination (IUI) cycles | 24.5 | 0 | 2 |
| Association of progesterone receptor polymorphisms with recurrent implantation failure after in vitro fertilization and embryo transfer | 24.5 | 0 | 2 |
| Hyaluronan in follicular fluid and embryo implantation following in vitro fertilization and embryo transfer | 24.5 | 0 | 2 |
| Comparison of embryo quality between intracytoplasmic sperm injection and in vitro fertilization in sibling oocytes | 24.5 | 0 | 2 |
| In vitro fertilization and embryo transfer: a brief overview | 24.5 | 0 | 2 |
| Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation | 24.5 | 0 | 2 |
| Estimating rates of multiple gestation pregnancies: sample size calculation from the assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial | 24.5 | 0 | 2 |
| Elevated day 3 follicle-stimulating hormone/luteinizing hormone ratio >or= 2 is associated with higher rates of cancellation in in vitro fertilization-embryo transfer cycles. | 24.5 | 0 | 2 |
| Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization | 24.5 | 0 | 2 |
| Predictive value of hormonal parameters for live birth in women with unexplained infertility and male infertility | 24.5 | 0 | 2 |
| Anti-mullerian hormone and antral follicle count as predictors of ovarian response in assisted reproduction | 24.5 | 0 | 2 |
| Impact of different embryo loading techniques on pregnancy rates in in vitro fertlization/embryo transfer cycles | 24.5 | 0 | 2 |
| The effectiveness of earlier oocyte retrieval in the case of a premature luteinizing hormone surge on hCG day in in vitro fertilization-embryo transfer cycles | 24.5 | 0 | 2 |
| Effect of seminal plasma application to the vaginal vault in in vitro fertilization or intracytoplasmic sperm injection treatment cycles—a double-blind, placebo-controlled, randomized study | 24.5 | 0 | 2 |
| The use of estradiol for luteal phase support in in vitro fertilization/intracytoplasmic sperm injection cycles: a systematic review and meta-analysis | 24.5 | 0 | 2 |
| Effects of polycystic ovarian syndrome on in vitro fertilization-embryo transfer outcomes are influenced by body mass index | 24.5 | 0 | 2 |
| The total pregnancy potential per oocyte aspiration after assisted reproduction—in how many cycles are biologically competent oocytes available? | 24.5 | 0 | 2 |
| Impact of GnRH ovarian stimulation protocols on intracytoplasmic sperm injection outcomes | 24.5 | 0 | 2 |
| Safety of assisted reproduction, assessed by risk of abnormalities in children born after use of in vitro fertilization techniques | 24.5 | 0 | 2 |
| Fatal colon cancer in a young egg donor: a physician mother's call for follow-up and research on the long-term risks of ovarian stimulation | 24.5 | 0 | 2 |
| Using the alkaline comet assay in prognostic tests for male infertility and assisted reproductive technology outcomes | 24.5 | 0 | 2 |
| Previous tubal ectopic pregnancy raises the incidence of repeated ectopic pregnancies in in vitro fertilization-embryo transfer patients | 24.5 | 0 | 2 |
| Comparison of the GnRH agonist and antagonist protocol on the same patients in assisted reproduction during controlled ovarian stimulation cycles | 24.5 | 0 | 2 |
| Influences on endometrial development during intrauterine insemination: clinical experience of 2,929 patients with unexplained infertility | 24.5 | 0 | 2 |
| Approach to Male Infertility and Induction of Spermatogenesis | 24.5 | 0 | 2 |
| Endometrial morphology and modulation of hormone receptors during ovarian stimulation for assisted reproductive technology cycles | 24.5 | 0 | 2 |
| Which is the best intrauterine insemination timing choice following exogenous hCG administration during ovulation induction by using clomiphene citrate treatment? A retrospective study | 24.5 | 0 | 2 |
| Complications in pregnancies after in vitro fertilization and embryo transfer | 24.5 | 0 | 2 |
| A comparison of the cost-effectiveness of in vitro fertilization strategies and stimulated intrauterine insemination in a Canadian health economic model. | 24.5 | 0 | 2 |
| Single-embryo transfer reduces clinical pregnancy rates and live births in fresh IVF and Intracytoplasmic Sperm Injection (ICSI) cycles: a meta-analysis | 24.5 | 0 | 2 |
| An evaluation of embryo, zygote and oocyte cryopreservation in assisted reproductive technology | 24.5 | 0 | 2 |
| Sperm freezing and in vitro fertilization in three substrains of C57BL/6 mice | 24.5 | 0 | 2 |
| Ovarian stimulation for in vitro fertilization alters the protein profile expression in endometrial secretion | 24.5 | 0 | 2 |
| Pregnancy, Delivery, and Neonatal Outcomes of In Vitro Fertilization-Embryo Transfer in Patient with Previous Cesarean Scar. | 24.5 | 0 | 2 |
| In Vitro Antioxidant Treatment of Semen Samples in Assisted Reproductive Technology: Effects of Myo-Inositol on Nemaspermic Parameters | 24.5 | 0 | 2 |
| Pregnancy Predictors after Intrauterine Insemination in Cases of Unexplained Infertility: A Prospective Study. | 24.5 | 0 | 2 |
| Assisted reproduction and fertility preservation techniques in cancer patients | 24.5 | 0 | 2 |
| Human choriogonadotropin prior to controlled ovarian stimulation and in vitro fertilization improves implantation, and pregnancy rates | 24.5 | 0 | 2 |
| Conjoined twins in a triplet pregnancy after intracytoplasmic sperm injection and blastocyst transfer: case report and review of the literature | 24.5 | 0 | 2 |
| The Role of Interleukin-18 in Serum and Follicular Fluid during In Vitro Fertilization and Intracytoplasmic Sperm Injection | 24.5 | 0 | 2 |
| Clinical efficacy of body mass index as predictor of in vitro fertilization and embryo transfer outcomes | 24.5 | 0 | 2 |
| Optimizing natural fertility | 24.5 | 0 | 2 |
| Glycine supplementation in vitro enhances porcine preimplantation embryo cell number and decreases apoptosis but does not lead to live births | 24.5 | 0 | 2 |
| Blastocyst expansion score and trophectoderm morphology strongly predict successful clinical pregnancy and live birth following elective single embryo blastocyst transfer (eSET): a national study | 24.5 | 0 | 2 |
| Pronuclear morphology evaluation for fresh in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) cycles: a systematic review | 24.5 | 0 | 2 |
| Comparison of easy and difficult embryo transfer outcomes in in vitro fertilization cycles | 24.5 | 0 | 2 |
| Relationship between Endometrial Thickness and In Vitro Fertilization-Intracytoplasmic Sperm Injection Outcome | 24.5 | 0 | 2 |
| Heterotopic pregnancy following in vitro fertilization and embryo transfer: 12 cases report. | 24.5 | 0 | 2 |
| Impact of female age and male infertility on ovarian reserve markers to predict outcome of assisted reproduction technology cycles | 24.5 | 0 | 2 |
| Transfer of spontaneously hatching or hatched blastocyst yields better pregnancy rates than expanded blastocyst transfer | 24.5 | 0 | 2 |
| Impact of GnRH analogues on oocyte/embryo quality and embryo development in in vitro fertilization/intracytoplasmic sperm injection cycles: a case control study | 24.5 | 0 | 2 |
| Application of in vitro maturation to assisted reproductive technology | 24.5 | 0 | 2 |
| Efficacy of metformin supplementation during ovarian stimulation of lean PCOS patients undergoing in vitro fertilization | 24.5 | 0 | 2 |
| Assisted reproductive technology use, embryo transfer practices, and birth outcomes after infertility insurance mandates: New Jersey and Connecticut | 24.5 | 0 | 2 |
| Human chorionic gonadotropin levels are equally predictive for pregnancy outcome after fresh and vitrified-warmed blastocyst transfer | 24.5 | 0 | 2 |
| Sperm Chromatin Dispersion Test before Sperm Preparation Is Predictive of Clinical Pregnancy in Cases of Unexplained Infertility Treated with Intrauterine Insemination and Induction with Clomiphene Citrate | 24.5 | 0 | 2 |
| Endometrial signaling pathways during ovarian stimulation for assisted reproduction technology | 24.5 | 0 | 2 |
| Costs of achieving live birth from assisted reproductive technology: a comparison of sequential single and double embryo transfer approaches | 24.5 | 0 | 2 |
| In vitro fertilisation (IVF) with donor eggs in post-menopausal women: are there differences in pregnancy outcomes in women with premature ovarian failure (POF) compared with women with physiological age-related menopause? | 24.5 | 0 | 2 |
| Evaluation of in vitro fertilization parameters and estrogen receptor alpha gene polymorphisms for women with unexplained infertility | 24.5 | 0 | 2 |
| comparison between Cleavage Stage versus Blastocyst Stage Embryo Transfer in an Egyptian Cohort Undergoing in vitro Fertilization: A possible Role for Laser Assisted Hatching | 24.5 | 0 | 2 |
| A strict infertility diagnosis has poor agreement with the clinical diagnosis entered into the Society for Assisted Reproductive Technology registry | 24.5 | 0 | 2 |
| Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients | 24.5 | 0 | 2 |
| Is there a difference in cognitive development between preschool singletons and twins born after intracytoplasmic sperm injection or in vitro fertilization? | 24.5 | 0 | 2 |
| Successful pregnancy and delivery of two sets of monozygotic twins after intracytoplasmic sperm injection and embryo transfer: case report and literature review | 24.5 | 0 | 2 |
| Two successful pregnancies achieved by converting an in vitro fertilization cycle to an intrauterine insemination cycle in five cases with documented premature ovulation | 24.5 | 0 | 2 |
| Reduced protein C Global assay level in infertile women prior to IVF-ET treatment | 24.5 | 0 | 2 |
| A comparative study on the results of agonist and antagonist protocols based on serum AMH levels in patients undergoing intracytoplasmic sperm injection | 24.5 | 0 | 2 |
| Improvement of pregnancy rate by intrauterine administration of dexamethasone and recombinant human leukemia inhibitory factor at the time of embryo transfer in cattle | 24.5 | 0 | 2 |
| Efficacy of combined contraceptive vaginal ring versus oral contraceptive pills in achieving hypothalamic-pituitary-ovarian axis suppression in egg donor in vitro fertilization cycles | 24.5 | 0 | 2 |
| Effect of intrauterine injection of human chorionic gonadotropin before embryo transfer on clinical pregnancy rates from in vitro fertilisation cycles: a prospective study | 24.5 | 0 | 2 |
| Pregnancy Rate after First Intra Cytoplasmic Sperm Injection- In Vitro Fertilisation Cycle in Patients with Endometrioma with or without Deep Infiltrating Endometriosis | 24.5 | 0 | 2 |
| Low-Dose Urinary Human Chorionic Gonadotropin Is Effective for Oocyte Maturation in In Vitro Fertilization/ Intracytoplasmic Sperm Injection Cycles Independent of Body Mass Index | 24.5 | 0 | 2 |
| Influence of endometrial thickness on treatment outcomes following in vitro fertilization/intracytoplasmic sperm injection | 24.5 | 0 | 2 |
| A systematic review and meta-analysis to determine the effect of sperm DNA damage on in vitro fertilization and intracytoplasmic sperm injection outcome | 24.5 | 0 | 2 |
| Renal artery dissection during an in vitro fertilization/intracytoplasmic sperm injection cycle | 24.5 | 0 | 2 |
| Validation of infertility treatment and assisted reproductive technology use on the birth certificate in eight states | 24.5 | 0 | 2 |
| Quality of embryos transferred and progesterone levels are the most important predictors of live birth after fresh embryo transfer: a retrospective cohort study | 24.5 | 0 | 2 |
| Fertility preservation with immature and in vitro matured oocytes | 24.5 | 0 | 2 |
| Day 3 ET, single blastocyst transfer (SBT) or frozen-thawed embryo transfer (FET): which is preferable for high responder patients in IVF/ICSI cycles? | 24.5 | 0 | 2 |
| Pregnancy outcomes and maternal and perinatal complications of pregnancies following in vitro fertilization/intracytoplasmic sperm injection using own oocytes, donor oocytes, and vitrified embryos: A prospective follow-up study | 24.5 | 0 | 2 |
| A rare and interesting case of heterotopic cervical pregnancy after intracytoplasmic sperm injection and embryo transfer | 24.5 | 0 | 2 |
| Economics of assisted reproduction: access to fertility treatments and valuing live births in economic terms | 24.5 | 0 | 2 |
| Semen preparation techniques in intrauterine insemination: A comparison of non-temperature and temperature controlled centrifugation in cases of unexplained infertility | 24.5 | 0 | 2 |
| What should be the first-line treatment for unexplained infertility in women over 40 years of age - ovulation induction and IUI, or IVF? | 24.5 | 0 | 2 |
| Hysterectomy in the Second Trimester of Pregnancy after In vitro Fertilization-embryo Transfer: A Case Report and Analysis of Its Risk Factors | 24.5 | 0 | 2 |
| Relationship between follicular fluid adipocytokines and the quality of the oocyte and corresponding embryo development from a single dominant follicle in in vitro fertilization/intracytoplasmic sperm injection cycles | 24.5 | 0 | 2 |
| Effect of Pertubation on Pregnancy Rates before Intrauterine Insemination Treatment in Patients with Unexplained Infertility | 24.5 | 0 | 2 |
| Impact of the endometrioma on ovarian response and pregnancy rate in in vitro fertilization cycles | 24.5 | 0 | 2 |
| 21-Hydroxylase-derived steroids in follicles of nonobese women undergoing ovarian stimulation for in vitro fertilization (IVF) positively correlate with lipid content of luteinized granulosa cells (LGCs) as a source of cholesterol for steroid synthe | 24.5 | 0 | 2 |
| Relationship of serum progesterone (P) level the day after human chorionic gonadotropin (hCG) injection on outcome following in vitro fertilization-embryo transfer (IVF-ET). | 24.5 | 0 | 2 |
| Severe systemic candidiasis following immunomodulation therapy in in vitro fertilisation-embryo transfer (IVF-ET) | 24.5 | 0 | 2 |
| Attitudes towards single embryo transfer, twin and higher order pregnancies in patients undergoing infertility treatment: a review | 24.5 | 0 | 2 |
| Asian Ethnicity and Poor Outcomes After In Vitro Fertilization Blastocyst Transfer | 24.5 | 0 | 2 |
| Inositol and In Vitro Fertilization with Embryo Transfer | 24.5 | 0 | 2 |
| Cumulative live-birth rates after assisted reproductive technology | 24.5 | 0 | 2 |
| Lack of Impact of Semen Quality on Fertilization in Assisted Conception | 24.5 | 0 | 2 |
| Human immunodeficiency virus and infertility treatment | 24.5 | 0 | 2 |
| Effect of Antioxidants (β-mercaptoethanol and Cysteamine) on Assisted Reproductive Technology In vitro | 24.5 | 0 | 2 |
| Random start or emergency IVF/in vitro maturation: a new rapid approach to fertility preservation | 24.5 | 0 | 2 |
| Improving fertility preservation for girls and women by coupling oocyte in vitro maturation with existing strategies | 24.5 | 0 | 2 |
| Clinical recommendation on fertility preservation in borderline ovarian neoplasm: ovarian stimulation and oocyte retrieval after conservative surgery | 24.5 | 0 | 2 |
| Luteal phase oocyte retrieval and in vitro maturation is an optional procedure for urgent fertility preservation | 24.5 | 0 | 2 |
| In vitro fertilization-embryo transfer in nonhuman primates: the technique and its applications | 24.5 | 0 | 2 |
| Human blastocyst culture in IVF: current laboratory applications in reproductive medicine practice | 24.5 | 0 | 2 |
| Fertility preservation and infertility treatment in breast cancer patients | 24.5 | 0 | 2 |
| The relationship between isolated teratozoospermia and clinical pregnancy after in vitro fertilization with or without intracytoplasmic sperm injection: a systematic review and meta-analysis | 24.5 | 0 | 2 |
| In vitro maturation of oocytes as a strategy for fertility preservation | 24.5 | 0 | 2 |
| World Suicide Prevention Day | 21.3 | 2 | 0 |
| Massachusetts General Hospital | 21.3 | 2 | 0 |
| Newsweek | 21.3 | 2 | 0 |
| World No Tobacco Day | 21.3 | 2 | 0 |
| World Health Day | 21.3 | 2 | 0 |
| World Tuberculosis Day | 21.3 | 2 | 0 |
| National Cancer Institute | 21.3 | 2 | 0 |
| World Blood Donor Day | 21.3 | 2 | 0 |
| World Hepatitis Day | 21.3 | 2 | 0 |
| World Malaria Day | 21.3 | 2 | 0 |
| BMJ | 21.3 | 2 | 0 |
| Epi Info | 21.3 | 2 | 0 |
| Weill Cornell Medicine | 21.3 | 2 | 0 |
| Yahoo! Finance | 21.3 | 2 | 0 |
| Boston Medical Center | 21.3 | 2 | 0 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | 21.3 | 2 | 0 |
| World Hearing Day | 21.3 | 2 | 0 |
| Preventing Chronic Disease | 21.3 | 2 | 0 |
| UpToDate | 21.3 | 2 | 0 |
| National Health Service | 21.3 | 2 | 0 |
| International Lead Poisoning Prevention Week | 21.3 | 2 | 0 |
| National Survey of Family Growth | 21.3 | 2 | 0 |
| National Vital Statistics System | 21.3 | 2 | 0 |
| NIOSH Power Tools Database | 21.3 | 2 | 0 |
| San Francisco AIDS Foundation | 21.3 | 2 | 0 |
| WHO Drug Information | 21.3 | 2 | 0 |
| Q20933367 | 21.3 | 2 | 0 |
| Luton and Dunstable University Hospital NHS Foundation Trust | 21.3 | 2 | 0 |
| Morbidity and Mortality Weekly Report: Recommendations and Reports | 21.3 | 2 | 0 |
| Vital & health statistics. Series 3, Analytical and epidemiological studies | 21.3 | 2 | 0 |
| Vital and health statistics. Series 3, Analytical studies | 21.3 | 2 | 0 |
| Vital and health statistics. Ser. 4, Documents and committee reports | 21.3 | 2 | 0 |
| Vital and health statistics. Series 13, Data from the National Health Survey | 21.3 | 2 | 0 |
| Harvard men's health watch | 21.3 | 2 | 0 |
| Harvard women's health watch | 21.3 | 2 | 0 |
| The Harvard mental health letter | 21.3 | 2 | 0 |
| Aging trends (Hyattsville, Md.) | 21.3 | 2 | 0 |
| NCHS data brief | 21.3 | 2 | 0 |
| MMWR supplements | 21.3 | 2 | 0 |
| National Center for Emerging and Zoonotic Infectious Diseases | 21.3 | 2 | 0 |
| Division of Parasitic Diseases and Malaria | 21.3 | 2 | 0 |
| Boscombe Community Hospital | 21.3 | 2 | 0 |
| Chronic Disease Prevention and Health Promotion | 21.3 | 2 | 0 |
| Cooper Health System | 21.3 | 2 | 0 |
| WHO Model List of Essential Medicines for Children | 21.3 | 2 | 0 |